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1.1.1 Phenomenon of fluorescence and phosphorescence
Phenomena now known as fluorescence and phosphorescence were mentioned in Chi-
nese books as far back as 1500 BC, but analysing, controlling and using these phenomena
started only 150 years ago. Fluorescence as a research topic was brought to light by Sir
George Gabriel Stokes. In 1852, he described the luminescence observed in the fluorspar
mineral (calcium fluoride) as fluorescence [1].
Today we know that fluorescence is just one type of luminescence. More specifically,
luminescence (Latin word lumen = light) is the ability of substances to emit light when
illuminated by a light source. Photon absorption can promote an electron from the S0
ground level to a vibrational level of the first electronic state (S1), or higher electronic
state (Sn, where n ≥ 2). In the time-range of 10−12 seconds or less electrons return to the
lowest vibrational level of S1. This process is called internal conversion (IC). Return of the
electron to S0 can result in two types of luminescence: fluorescence or phosphorescence.
When the electron returns from S1 to S0 we speak of fluorescence emission. Substances
which are able to emit fluorescence are known as fluorophores. For small organic molecules
fluorescence typically occurs in the time-range of 10−8 seconds. Phosphorescence occurs
when the electron in the first electronic excited state (S1), instead of returning to the S0,
undergoes a spin conversion to the first triplet state, T1. This process from S1 to T1,
is called intersystem crossing (ISC) and occurs at a similar time range as fluorescence.
The electron in T1 has the same spin orientation as the electron in the S0 orbital from
which it originated. Return of the electron from T1 to S0 is very slow as this is a so called
forbidden transition. Phosphorescence typically occurs in the time-range of milliseconds
to seconds. The processes that occur upon the absorption of a photon can be presented
schematically in a Jablon´sky diagram [2] (Figure 1.1).
1.1.2 Quantum yield and fluorescence lifetime
Two important characteristics of a fluorophore are its fluorescence lifetime (τ) and its
quantum yield (Q). The fluorescence lifetime is the average time the fluorophore spends
in the excited state. The fluorescence lifetime is equal to the reciprocal of the sum of all







Γ - emission rate of the fluorophore∑
knr - sum of all non-radiative decay processes
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Figure 1.1: Jablonski diagram
The lifetime of the uorophore in the absence of non-radiative processes is called




χn is a property of the molecule and is usually not sensitive to the uorophore microen-
vironment while the magnitude of

knr is dependent on the microenvironment. The
uorescence quantum yield (Q) is the ratio of the number of emitted photons to the num-








The quantum yield ranges from 0 1. If knr then Q approaches 0. In the ideal
case when knr = 0 all absorbed photons are emitted as uorescence, and Q = 1. Because
the value of Q is always changing with knr, a change of the uorophore s microenvironment
often results in a measurable change in the quantum yield.
1.1.3 Quenching of uorescence
The process resulting in a decrease of the uorescence intensity of a uorophore is
known as quenching. Fluorescence quenching can be caused by many di erent molecular
processes such as excited-state reactions, radiationless energy transfer, or complex for-
mation with a quencher [3]. Collisional or dynamic quenching is a process in which the
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Figure 1.2: Quinone quenching with potassium iodide. Left: Quinone solution with
potassium iodide, Right: Quinone solution without potassium iodide
fluorophore in the excited state collides with a quencher. This collision results in radia-
tionless de-excitation of the fluorophore. In the case of static quenching, a non-fluorescent
complex between fluorophore and quencher is formed. Many compounds are known as
quenchers of fluorescence. For small aromatic fluorophores, like indole, good quenchers
are iodide, amines and electron deficient molecules like acrylamide. The potential of a col-
lisional quencher to suppress fluorescence of a certain fluorophore can be investigated in a
Stern-Volmer (S-V) quenching experiment. The extent of quenching at different quencher
concentrations is recorded and analysed using the S-V equation:
F0
F
= 1 + kqτ0[Q] = 1 +KSV [Q] (4a)
F0 - The emission intensity in the absence of quencher.
F - The emission intensity in the presence of quencher.
kq [M
−1s−1] - The collisional quenching constant.
τ0 [s] - The lifetime of the fluorophore in the absence of quencher.
KSV [M
−1] - Stern-Volmer constant (quencher concentration at which 50% of the inten-
sity is quenched.
[Q ]- The concentration of a quencher.
When a linear S-V plot, F0F versus [Q], is obtained all fluorophores are equally
accessible to the quencher. If the S-V plot shows a downward curvature the solvent acces-
sibility is not equal for all fluorophores in the sample. An upward curvature is observed if
both a dynamic and a static quenching mechanism are operative. Collisional quenching
experiments are widely used for determining the solvent accessibility of tryptophan in a
protein [4, 5, 6, 7, 8] (Figure 1.3). If the tryptophan is buried inside the protein, quenching
is not expected to be very efficient, yielding a low kq and KSV value. If the tryptophan
residue is on the protein surface then efficient quenching is expected, with a kq value ap-
proaching the diffusional rate constant of the quencher. Proteins usually contain several
1.1 Fluorescence 5
Figure 1.3: Fluorescence quenching of W20 LysM protein with potassium iodide.
Square: in the absence of the ligand (peptidoglycan); tryptophan well accessible to KI. Circles:
in the presence of the ligand; tryptophan less accessible to KI. Unpublished data.
tryptophan residues that are at distinct environments. If each of these residues shows a
dierent accessibility to the quencher a downward curvature will be obtained.
1.1.4 Steady-state and time-resolved uorescence
Fluorescence spectroscopy measurements can be performed in either steady state
or in time-resolved mode. In steady-state uorescence experiments, the uorophore is
constantly illuminated and its uorescent properties investigated. In time-resolved mea-
surements the uorophore is excited by a short pulse of light and the induced uorescence
intensity (I(t)) is monitored in time. If the uorophore displays a single χ, I(t) can be
described by equation 2a:
I(t) = I0  e ( t ) (2a)
I0 - The uorescence intensity at time t = 0.
χ - The uorescence lifetime of the uorophore.










Figure 1.4: Fluorescence emission spectra and emission intensity dependence on [Q]:
surface-accessible (right) and surface-buried (left) tryptophan residues in proteins. Data from [9].
with τi as the i
th lifetime with amplitude αi.
The steady-state emission intensity is just an average of the signal collected in a time
resolved measurement. As a result of this averaging, valuable information about the sam-
ple is lost. For example if two identical fluorophores are experiencing different microen-
vironments in a sample, it is not possible to assign their individual Q via steady-state
fluorescent experiments (unless their emissions spectra are resolved). In time-resolved
mode this is possible. If the fluorophore experiences different microenvironments, a set of
different lifetimes is expected.
1.1.5 Fluorescence anisotropy
In an anisotropy measurement the fluorescent sample is excited with polarized light
and the emission intensity is measured either parallel (I‖) or perpendicular (I⊥) to the





with I‖ and I⊥ the fluorescence intensities when the emission polarizer is oriented parallel
or perpendicular to the direction of the polarized excitation, respectively.
A fluorophore excited by polarized light also emits polarized light. However, if the
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molecule can rotate while emitting, the direction of the emission will randomise, resulting
in a lower anisotropy. In the case when no other processes than rotation result in loss of
anisotropy, (r) can be described by the Perrin equation (equation 3b):




r 0 - fundamental anisotropy equal to the anisotropy of the fluorophore in the absence of
rotational diffusion (at the selected excitation wavelength)
θ - rotational correlation time








· (ν + h) (3c)
where η is the viscosity in poise (P), T is the temperature in K, R is ideal gas constant
(8.31 J/molK), M is the molecular weight (g/mol), and (ν + h) is the specific volume
(dm3) of the macromolecule including its hydration shell.










The volume of the fluorescent macromolecule can be determined if the anisotropy of
the macromolecule is measured over a range of temperatures or viscosities, and the data
plotted in a graph with 1r at the y-axis and
T
η at the x-axis. Extrapolation
T
η to 0 (a very
high η) gives the fundamental anisotropy of the macromolecule ( 1r0 ) while the slope of the
plot represents τRr0V (Figure 1.5).
Determination of the volume of a fluorescent macromolecule via the Perrin equation
only works well if the τ of the fluorophore is not too different from θ. If the fluorophore
can also rotate fast, independently of the rotation of the protein, a very low r value is
obtained as τθ in equation 3b becomes >> 1. As a result r will be minimally dependent
on θ preventing a reliable determination of the size of the macromolecule. θ values can in
general be determined more easily and accurately in time-resolved anisotropy experiments.
In a time-resolved anisotropy experiment the decay of the anisotropy in time, r(t), is





with I‖(t) and I⊥(t) as the detected emission intensity in time with the emission polarizer
in parallel or perpendicular orientation relative to the excitation light source, respectively.










Figure 1.5: Perrin plot. Data from [10].
where Φj is the j
st rotational correlation time with amplitude r0j .
As the fluorescence anisotropy is sensitive to changes of the fluorophore rotation, these
measurements are widely used to study the interactions between biological macromolecules
(e.g. protein - ligand or protein-protein interactions).
1.1.6 Biochemical fluorophores
Biochemical fluorophores can be divided into two general classes, intrinsic and ex-
trinsic fluorophores. Intrinsic fluorophores are those, which occur naturally. In proteins,
the most interesting intrinsic fluorophore is the indole group of tryptophan, and it will be
described in detail in the next section. Beside tryptophan also tyrosine and phenylala-
nine show fluorescent properties. The chromophore p-hydroxybenzylideneimidazolinone is
formed from Ser65-Tyr66-Gly67 residues during folding of green fluorescent protein (GFP)
from Aequorea victoria (Figure 1.6). It shows an intense absorption band at 395 nm and
a minor one at 475 nm. Its emission peak is at 509 nm and the fluorescence quantum
yield is very high, 0.79 [11]. Introduction of a single point mutation (S65T) in GFP was
shown to result in an increase in Q and photostability, and a shift of the major excitation
peak to 488 nm, without inducing a change in λmax [12]. This improved GFP variant and
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Figure 1.6: Autocatalytic fluorophore formation observed in green fluorescent pro-
teins. Data from [12].
other GFP mutants have found widespread use in protein biochemistry and biology [13].
NADH, pyridoxal phosphate, riboflavine, FAD, and FMN are examples of fluorescent co-
factors. When the biomolecule of interest is not fluorescent (e.g. lipids or DNA) or when
the intrinsic fluorescence is not adequate, the biomolecule can be labelled with an extrin-
sic fluorescent probe. Numerous fluorophores are available for covalent and noncovalent
labelling of proteins. For example, the fluorophore dansyl chloride (DNS-Cl) reacts with
amino groups of proteins forming sulphon-amido linkages as the most important product
of the reaction [14]. DNS-Cl can be excited at 350 nm, a wavelength where proteins do
not absorb, and the emission maximum is near 520 nm [3]. Popular fluorophores which
are commonly used to label proteins noncovalently are 1-anilino-8-naphthalene sulfonate
acid (ANS) and 6-(p-toluidinyl)naphthalene-2-sulfonic acid (TNS) [15].
1.2 Protein fluorescence and tryptophan analogues
1.2.1 Tryptophan as an intrinsic protein fluorophore
The chemical modification of a protein can affect its structure and functional prop-
erties. Intrinsic fluorescent probes allow a biological system to be observed with no or
minimal perturbations of the native structure. Tryptophan has been extensively used
as intrinsic probe for studying protein structure, dynamics and local environment [16].
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Figure 1.7: The anisotropy-resolved spectra of the 1La (circles) and
1Lb (dots) tran-
sitions of indole in vitrified propylene glycol. The absorption spectrum of indole is also
shown. Data from [3].
Its absorption at wavelengths longer than 295 nm allows tryptophan to be excited in-
dependently of the other two aromatic amino acids, tyrosine and phenylalanine [10, 16].
Tryptophan is the least abundant amino acid residue in proteins1 and when the protein
contains only one Trp residue, interpretation of the spectral data is most straightforward.
The photophysics of tryptophan is quite complex because the energies of the S1 and S2
excited states (Figure 1.1) overlap with each other. These two excited states, also known
as 1La and
1Lb states [17], are responsible for the Trp absorption spectrum centred around
270 nm. Because of the overlap, specific excitation of either the 1La or
1Lb state is not
possible, except when excitation takes place at the red edge of the spectrum, where only
1La absorbs (see Figure 1.7). The
1La state is always the fluorescent state of indole except
for indole in vacuum, or when dissolved in perfluorohexane [18]. Excited-state conversion
from 1Lb to
1La is known to be very fast compared to the fluorescence lifetime and
1La
is almost always the emitting state in proteins [3]. Only a small number of single Trp
mutants of the transhydrogenase domain I protein are known to show emission from 1Lb
state [19].
The 1La state has a much larger dipole moment than Trp in the ground state,
1Tryptophan is generally present at about 1 mol% in proteins [3].
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while the dipole moment of the 1Lb state is small and comparable to the ground state [20].
As a result of the large dipole moment of the fluorescing 1La state, a large Stokes shift can
be observed for Trp in a polar medium. Depending on the position of Trp in a protein,
the λmax ranges from 304 nm for a Trp in an occluded apolar microenvironment [20] to
355 nm for a Trp at a surface exposed position [21]. Beside λmax, also the Q of Trp is
highly sensitive for changes in the microenvironment. At 23 0C in aqueous solution at pH
7 the quantum yield of tryptophan is 0.14 and the emission maximum ≈ 350 nm [22], but
the Q of Trp in a protein can vary from almost 0 to 0.35 [23]. Changes in Trp fluorescence
can be used to monitor protein (un)folding, or conformational changes of protein-ligand
interactions.
1.2.2 Tryptophan analogues
Alloproteins are proteins that contain non-canonical amino acids. Incorporation of
Trp analogues in proteins was already described in the 1950s, and the aim of those studies
was to elucidate metabolic pathways and the mechanism of protein synthesis [24, 25,
26]. In these first reports the alloproteins were not purified and characterized. The first
description of a purified protein in which tryptophan was replaced by a Trp analogue (7-
azatryptophan (7AW) and 2-azatryptophan (2AW)), was in 1956 [27]. In the 1970s several
groups reported the incorporation of fluorotryptophans (FW) into proteins aiming to study
the labelled proteins via 19F NMR [28]. The introduction of artificially inducible promoters
in the 1980s [29] as a common approach for protein expression opened possibilities for
more proficient incorporation of Trp analogues. In the early 1990’s protocols for the
incorporation of Trp analogues in recombinant proteins were published [30, 31]. The
new approach enabled incorporation efficiencies for 7AW, 5-hydroxytryptophan (5HW),
and 5-fluorotryptophan (5FW) analogues between 50% and ≥95% [22]. Most work in
this field is focused on the incorporation of these three analogues. 7AW and 5HW show
significant red-shifted absorption spectra compared to Trp (Figure 1.8), which facilitates
their selective excitation in the presence of Trp at wavelengths >305 nm. This selective
excitation is also known as spectral edge excitation.
Besides the red-shifted absorbance of some Trp analogues, also other spectroscopic
properties of Trp analogues can be exploited in protein chemistry. An attractive property
of 7AW is its very high sensitivity of the quantum yield to a change in microenvironment.
Free 7AW in neutral aqueous solutions is almost non-fluorescent (Q = 0.017) [32], while
in a protein Q values of ≈ 0.5 have been reported [22]. 7AW in buffer features a 40 nm
red-shifted emission maximum compared to Trp, [32, 33, 34]. The red-shift in emission
maximum of 7AW was related to a larger dipole moment of the excited state compared
to Trp [35]. The large sensitivity of 7AW for changes in microenvironment makes 7AW
an interesting probe to examine protein-folding or protein conformational changes, also if
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Figure 1.8: Absorption spectra of Trp and Trp analogues.
Trp-containing proteins are presented in the sample [22]. 5HW in neutral aqueous solution
shows a quantum yield almost twice as high as Trp, 0.27 vs. 0.14, and features an emis-
sion maximum at 336 nm [32]. The blue-shifted emission maximum of 5HW, compared
to Trp, has been related to 1Lb being the emitting state of 5HW. The
1Lb state has a
much smaller excited-state dipole moment than 1La and this explains the low sensitivity
of λmax for a change in 5HW microenvironment [22, 36]. In 5HW the
1Lb state can be
selectively excited at wavelengths above 310 nm [22]. Specific excitation of the 1Lb state
avoids depolarization of 5HW fluorescence emission due to internal conversion from 1La
to 1Lb state. The higher intrinsic anisotropy value of 5HW compared to Trp, makes 5HW
an attractive probe in fluorescence anisotropy measurements [30]. 5HW as free amino
acid in aqueous solution at neutral pH shows a mono exponential decay. However, when
incorporated in proteins two or three lifetimes are observed [37]. Another interesting Trp
analogue is 5-fluorotryptophan. The fluorescence decay kinetics of a protein containing
5FW is more homogeneous than the decay kinetics of Trp at the same position. Often
a monoexponential decay is observed [38], as well as a Q of ≈ 0.22 [39] making 5FW an
attractive energy donor in time-resolved resonance energy transfer experiments [40]. Re-
placing Trp residues with 4FW converts the protein into a fluorescently ”silent” protein, as
4FW is not fluorescent. Labelling a protein with 4FW allows monitoring the fluorescence
of another Trp-containing protein in the same sample (for example in protein-protein
1.2 Protein uorescence and tryptophan analogues 13
Figure 1.9: Numbering of indole substitution positions.
interaction studies) [41].
1.2.3 Aminoacyl-tRNA synthetase
During translation each of the 20 canonical amino acids is enzymatically coupled
to its cognate tRNA in an aminoacylation reaction catalysed by an amino acid speci c
aminoacyl-tRNA synthetase (aaRS). The tRNA coupled with its cognate amino acid (i.e.
aminoacyl-tRNA) enters the ribosome where it participates in the decoding of the mRNA
(via codon-anticodon interactions) and the attached amino acid is coupled to the nascent
polypeptide chain via formation of a peptide bond. The coupling of the amino acid to its
cognate tRNA is accomplished in a two-step reaction [42].
AA + ATP + aaRS aaRS AA-AMP + PPi (1)
aaRS AA-AMP + tRNA aaRS + AA-tRNA + AMP (2)
Acylation of tRNA with another amino acid than the cognate one can give rise to
mutations in proteins [43]. Consequently, the substrate speci city of aaRS towards amino
acid and tRNA is known to be very high, ensuring a high delity of the translation process.
For example, although the structure of Phe compared to Tyr di ers by only a hydroxy
group, its attachment to tRNATyr is highly discriminated by TyrRS [44]. The capability
of the hydroxy group in Tyr to form two hydrogen bonds is maximally exploited during
formation of the TyrRS  Tyr complex. This binding energy is not available when Phe
binds to TyrRS. The high substrate speci city of aaRS limits the incorporation of amino
acid analogues to those structures showing high resemblance to natural amino acids.
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1.2.4 Strategies to improve incorporation of amino acid analogues
in recombinant proteins
Amino acid analogues can be incorporated in recombinant proteins, via an: (1) in
vitro or (2) in vivo incorporation methodology. In vitro methods use a chemical aminoa-
cylation step to label the tRNA in a cell-free translation system with the non-canonical
amino acid. This is a versatile method for the incorporation of non-canonical amino acids,
as also amino acids with side chain structures significantly different from the canonical
amino acids can be introduced in proteins in this way. However limitations of this method
are a low protein yield, and lack of natural posttranslational modifications of proteins [45].
In vivo methods for the incorporation of amino acid analogues use amino acid aux-
otroph strains (e.g. a Trp auxotroph), of which the expression system is under the control
of a non-leaky promoter. In this method the growth medium, which contains the natural
amino acid, is replaced with a medium containing the amino acid analogue of choice,
before protein induction is started. Compared to the in vitro methods, this approach is
experimentally simpler and often results in a similar recombinant protein yield as when a
non-auxotrophic strain is used.
Aminoacyl tRNA synthetases (aaRS) were identified as ”the bottleneck” for the in-
corporation of non-natural amino acids [46]. Much research in this field is directed toward
engineering the aaRS activity to accepting non-canonical amino acids. Strategies used to
extend the number of non natural amino acids which can be translated in vivo are: (1) re-
designing of the amino acid binding pocket in aaRS [47], (2) overexpression of aaRS in the
expression host [48, 49] and (3) creating an orthogonal aaRS/tRNA pair [50, 51, 52, 53].
Also, exploring the translation capability of a different expression host towards unnatural
amino acids can result in the biosynthetic incorporation of new amino acid analogues [54].
In chapter 3 we explored the translation capability of L. lactis in order to incorporate
Trp analogues in a recombinant protein, which can not be incorporated using E. coli as
expression host.
1.3 LysM domain
The Lysin motif (LysM) is a widely spread motif in nature and its biological function
is binding of peptidoglycan (PG) in the cell walls of bacteria or chitin-like compounds in
eukaryotes [55]. The LysM was first discovered in the lysozyme of Bacillus phage φ29
[56]. Many proteins contain a LysM domain, which consists of only one LysM motif, such
as the prophage amidase XlyA of Bacillus subtilis [57], while in others, LysM domain
consists of several motifs [58, 59, 60, 61]. LysM motifs typically range in length from 44
to 65 amino acids residues [55]. LysM domain is separated from the catalytic part of the
protein by a short spacer. Also, in proteins where the LysM domain consists of two or
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Figure 1.10: NMR structure of MltD-LysM2 of E. coli (Left panel) and the 3D
model of AcmA-LysM1 (right panel). N- and C- termini, α helixes, and β strands are
highlighted in the structure of MltD-LysM2 and the model of AcmA-LysM1.
more motifs, the motifs are separated by short spacers of 7 - 15 amino acid residues, rich
in Ser, Thr, Asp or Pro residues, which may form a flexible region between LysM motifs
[62]. LysM domains can be present at the N-terminal part of protein (e.g. LytF of B.
subtilis), at the C-terminal part (e.g. AcmA of L. lactis) or present in the central part of
a protein (e.g. XlyA of B. subtilis) [55].
1.3.1 The structure of LysM domain
To date only four LysM domain structures have been solved. The structure of the
LysM domain from the lytic murein transglycosylase MltD of E. coli [63], the structure of
the B. subtilis spore protein YkuD [61], a LysM structure belonging to the human hypo-
thetical protein SB145 [64], and more recently, a CVNH-LysM lectin from the rice blast
fungus Magnaporthe oryzae [65]. All four LysM structures show an α1β1β2α2 secondary
structure with the two α-helices packing at the same side of an antiparallel β-sheet (Figure
1.10). Sequence alignment of LysM motifs from several species revealed that conserved
amino acids are mostly positioned in turns between the secondary structure elements.
These conserved amino acids probably play a role in the correct positioning of the α-
helices and β-strands in LysM [55]. Characterization of the carbohydrate binding site
using calorimetry and NMR techniques were employed to identify residues critical for lig-
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Figure 1.11: Structure of a MltD LysM motif showing the position of GDSL in the
putative ligand binding site (left: front view, right: back view). G, S, and L are shown in
pink and D in black.
and binding in two LysM motifs of the chitinase of P. ryukyuensis [66]. A shallow groove
is formed by a cluster of hydrophobic residues at the N-terminal part of the α1 and the
loop between the β1 and the α1, together with the C-terminal part of β2 and the loop
connecting α2 and β2. Ohnuma et. al. proposed this shallow groove functions as ligand
binding site of the LysM motif [66]. Conserved Gly10 and Gly21 residues are found in
short turns between the β-strands and α-helices, the highly conserved Asp28 (nomencla-
ture of Buist et al. [55]) seems to form a turn at the end of the second α-helix. A highly
conserved G D T/S L sequence is also present in LysM motifs [55] (Figure 1.11) and it
has been proposed that Asp in this sequence plays a role in ligand binding, as well as the
conserved Thr/Ser and Gly residues [67].
1.3.2 LysM domain of the N-acetylglucosoaminidase AcmA of L.
lactis
The LysM domain from N-acetylglucosaminidase (AcmA) of L. lactis is the most
intensively studied LysM domain [62, 68, 69, 60, 70]. AcmA is a 40.3 kDa cell wall
hydrolase of L. lactis, involved in cell separation after cell division [62]. It consists of two
motifs, an N-terminal glucosaminidase domain, and a C-terminal cell-wall binding LysM
domain. The LysM domain of AcmA consists of three highly homologous motifs. The
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size of each motif is 45 amino acids, and they are separated by nonhomologous spacer
sequences [62]. Binding of AcmA to L. lactis cells was found to be highly dependent
on the number of LysM motifs. Two of the three LysM motifs are needed for efficient
binding of AcmA to the cell-wall [69]. Steen et al. showed that the LysM domain of
AcmA binds to many gram-positive bacteria with different PG structures [60]. The only
common part of all analysed PG structures is a disaccharide building block consisting
of N-acetylglucosamine and N-acetylmuramic acid. This result suggests that the AcmA
LysM domain most likely binds to this component of the PG [55]. Immunofluorescence
microscopy revealed that the AcmA LysM domain interacts with specific loci on the cell
surface [60]. Chemical treatment of L. lactis cells and cell-walls using trichloracetic acid
(TCA) removes components responsible for preventing LysM domain recognition. This
treatment yields so called bacterium like particles (BLPs). Cells and cell-walls treated
this way show a much higher binding capacity toward LysM domains [71, 72]. BLPs found
application in vaccines through the intranasal route, which is an attractive alternative to
conventional intramuscular injection vaccines [73].
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1.4 Thesis outline
Because of its attractive spectroscopic characteristics, Trp is often used as an intrin-
sic fluorophore in proteins. Its fluorescence emission maximum and quantum yield are
strongly dependent on the microenvironment and can provide us with information about
protein structure or protein - ligand interactions [16].
In biochemical systems where more than one Trp-containing protein is present, the
interpretation of the Trp fluorescence data can be difficult or even impossible. One way
to overcome this limitation is the biosynthetic replacement of a specific Trp by a Trp
analogue with different spectroscopic properties. Trp substitution by a Trp analogue with
different spectroscopic properties leads to spectrally enhanced recombinant proteins [22].
In Chapter 2 four functional single-Trp LysM mutants and one double Trp LysM
mutant were constructed and biosynthetically labelled with 7AW or 5HW. These Trp
analogues feature red-shifted absorption spectra, and enabled monitoring of the LysM -
ligand interaction in media with a Trp background. The method described in this chapter
can be used for the detection of low levels of peptidoglycan or microbes in solutions.
In Chapter 3 an expression system is presented that allows efficient incorporation
of chloro- and bromo- atoms containing Trp analogues in alloproteins at high expres-
sion levels using a Lactococcus lactis Trp auxotroph strain. Coexpression of the enzyme
tryptophanyl-tRNA synthetase of L. lactis (lacTrpRS) was essential for the biosynthetic
incorporation of these analogues and also for incorporating 5,6 difluoroTrp. The presented
expression system features the most relaxed specificity for Trp analogues reported to date
and gives a high alloprotein yield.
In Chapter 4 the intrinsic anisotropy of free 5HW and of four proteins labelled with
5HW was exploited in order to clarify which state emits in 5HW, the 1La or
1Lb state.
The obtained results provided the first experimental evidence that 1La can be the emitting
state for this Trp analogue incorporated in a protein.
Chapter 2
Monitoring LysM-ligand interactions via tryptophan
analogue fluorescence spectroscopy
Dejan M. Petrovic´, Kees Leenhouts, Maarten L. van Roosmalen, Fenneke
KleinJan, Jaap Broos
Published in Anal. Biochem., 2012, Volume: 428, page: 111-118.
20 Monitoring LysM-ligand interactions via tryptophan analogue fluorescence spectroscopy
2.1 Abstract
The lysin motif (LysM) is a peptidoglycan-binding protein domain found in a wide
range of prokaryotes and eukaryotes. Various techniques have been used to study the
LysM-ligand interaction but a sensitive spectroscopic method to directly monitor this in-
teraction has not been reported. Here a tryptophan analogue fluorescence spectroscopy
approach is presented to monitor the LysM-ligand interaction using the LysM of the N-
acetylglucosaminidase enzyme of Lactococcus lactis. A 3D model of this LysM protein
was built based on available structural information of a homologue. This model allowed
choosing the amino acid positions to be labelled with a Trp analogue. Four functional
single-Trp LysM mutants and one double Trp LysM mutant were constructed and biosyn-
thetically labelled with 7-azatryptophan or 5-hydroxytryptophan. These Trp analogues
give red-shifted absorption spectra, enabling the monitoring of the LysM-ligand interac-
tion in media with a Trp background. The emission intensities of four of the five LysM
constructs were found changing markedly upon exposure to either L. lactis bacterium-like
particles or purified peptidoglycan as ligands. The method reported here is suitable to
monitor LysM-ligand interactions at (sub)micromolar LysM concentrations and can be
used for the detection of low levels of peptidoglycan or microbes in solutions.
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2.2 Introduction
Peptidoglycan (PG) is a biopolymer consisting of glycan chains of alternating N-
acetylglucosamine and N-acetylmuramic acid residues, cross-linked by peptide bridges.
Its presence in the bacterial cell wall provides structural strength to the cell, and counter-
acts the osmotic pressure of the cytoplasm. For growing and dividing, bacteria produce
enzymes that can hydrolyse bonds in the peptidoglycan matrix [74]. These enzymes are se-
creted and attached in a non-covalent manner to the cell wall via specific protein domains,
Lysin Motif (LysM) domains [55]. The LysM domain is separated from the catalytic part
of the enzyme by a short spacer, it can appear either at the N-terminus or at the C-
terminus of the proteins, and sometimes is present in the central part of proteins [55].
The LysM domain is mostly found in enzymes that degrade bacterial cell walls [75]. A
LysM containing protein can hold in between one to twelve LysM motifs, separated from
each other by short spacers [76, 58, 59]. A LysM motif typically contains 42 to 65 amino
acid residues and spacers usually consist of 7 - 33 amino acid residues which may form
a flexible region between LysM motifs [62]. The structures of several LysM motifs have
been determined by nuclear magnetic resonance (NMR) spectroscopy or X-ray crystallog-
raphy: MltD of E. coli, YkuD from Bacillus subtilis, human hypothetical protein SB145
and more recently a CVNH-LysM lectin from the rice blast fungus Magnaporthe oryzae
[64, 65, 63, 61]
More than 4000 proteins of both prokaryotic and eukaryotic origin have been found to
contain a LysM domain [55]. One of the best-characterized LysM domains is the one from
N-acetylglucosaminidase, AcmA, of Lactococcus lactis [62, 68, 70, 69]. AcmA contains
three LysM motifs at the C-terminal end (Figure 2.7). The primary sequence of these
motifs differs slightly. Binding studies using the C-terminal part of AcmA containing the
three LysM motifs identified PG as the component of the cell wall to which LysM binds
[60]. To achieve sufficient affinity for the cell wall at least two LysM motifs are needed [69].
Despite an increasing number of reports in which PG is identified as the LysM binding
component [57, 58, 59, 60, 69, 55] the mode of its interaction at the molecular level is still
unknown.
Techniques that have been used to study the interaction between LysM domains and
cell walls or PG include halo formation, cell separation and sedimentation [69, 68], im-
munofluorescence [60], isothermal calorimetry, NMR [66], and atomic force microscopy
[77]. A spectroscopic method in which only minute amounts of LysM are needed and al-
lowing the direct monitoring of the binding event has not been presented. Such a method
will not only be useful to find new ligands but could also find application in a biosensor
for the detection of PG or microbes with LysM as molecular recognition element. This
work a fluorescence methodology is presented to monitor the binding interactions between
LysM and its substrates, by taking advantage of the intrinsic fluorescence properties of
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LysM domain. To make this possible, we created four single Trp LysM mutants and one
LysM construct with two Trp residues. Each recombinant protein consists of two LysM
motifs (LysM tandem). An enzyme-linked immunosorbent assay (ELISA) was developed
to verify the binding functionality of the newly constructed LysM tandems. To monitor
interactions with cell walls or PG in the presence of other proteins, we biosynthetically
labelled the LysM tandem with Trp analogues featuring a red-shifted absorption. The red-
shifted absorption spectra allow specific excitation in a Trp background. 7-azatryptophan
(7AW) and 5-hydroxytryptophan (5HW) show this feature [37, 78, 79, 22]. Recently, we
reported the use of a L. lactis tryptophan auxotroph as host to incorporate 7AW and
5HW tryptophan analogues [54], and this host was used in this study.
Mixing µM concentrations of 7AW or 5HW labelled LysM tandems with purified PG
[80] or with acid treated L. lactis cells called bacterium-like particles (BLPs) [71, 72] re-
sulted in marked changes in the fluorescence emission of most LysM tandem constructs
investigated. The developed method offers great potential to study the interactions be-
tween LysM motifs and their ligands in more detail.
2.3 Materials and methods
2.3.1 Chemicals
D,L-7AW and L-5HW were obtained from Sigma-Aldrich.
2.3.2 LysM ligands
PG was purified from lyophilized cells of Brevibacterium lactofermentum as described
previously [80]. Briefly, lyophilized cells of B. lactofermentum were resuspended in 1%
sodium dodecylsulfate (SDS), stirred at room temperature for 12 h, and then centrifuged.
This procedure was repeated 16 times. SDS was removed from the suspension by repet-
itive washing with water. Proteins in the suspension were subsequently digested using
trypsin from porcine pancreas (Sigma-Aldrich). The trypsin was inactivated by shaking
the suspension at 90 ◦C for 20 min and was subsequently washed six times with an aque-
ous solution of 5 ×10−4 M ethylenediaminetetraacetic acid (EDTA) followed by repetitive
washing with water. In this protocol, the cells are not treated with strong acid, a step
known to remove cell wall polysaccharides, as demonstrated for L. lactis cells [81]. Be-
cause this sample likely contains some polysaccharides other than PG, we refer to it as
”purified cell walls” in this work.
The PG chain length distribution of the purified cell walls was not determined and
has not been reported for B. lactofermentum. The obtained distribution depends on the
isolation procedure and the type of cells used. For example, the protocol employed in this
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work results in an average PG chain length of approximately 100 hexosamines if Spirillum
serpens cells are used [80], whereas L. lactis cells, following a different procedure give 26%
to 43% of PG chains with more than 50 hexosamines [82].
BLPs were produced exactly as described previously [71, 72]. Briefly, L. lactis MG1363
cells from a fresh overnight culture were diluted 100-fold in 500 ml of fresh GM17, and
the standing culture was left to grow for 16 h at 30 ◦C. Cells were collected by centrifu-
gation (10 min, 13,000 g) and washed once by addition of 250 ml of sterile distilled water,
vortexed, and centrifuged. Subsequently, 100 ml of 0.6 M trichloroacetic acid (TCA) was
added to the pellet, and the cell suspension was placed in boiling water for 30 min in a
tube under atmospheric pressure. Next, the cells were washed three times in 250 ml of
sterile phosphate-buffered saline (PBS) with vigorous vortexing. After the last washing
step, cells were taken up in 50 ml of PBS. The number of BLPs per millilitre was deter-
mined microscopically with a Burker-Turk counting chamber.
Because both the purified cell walls and BLP samples are not uniform in composition,
their concentration cannot be expressed in molarity concentration units, and so milligrams
per millilitre (mg/ml) was used instead.
2.3.3 General DNA techniques
Standard recombinant DNA techniques were performed as described previously [83]
or as specified by the manufacturers. Enzymes and buffers were purchased from BioLabs-
New England or Roche.
Plasmid pPA40 (laboratory collection, table 1) containing the gene fragment encod-
ing the most N-terminal AcmA LysM motif, AcmA-LysM1, including signal sequence, 14
amino acid spacer, and a ”c-myc” region encoding an epitope for immunodetection at
its N-terminus, was used to create Trp-less AcmA-LysM1. Trp at position 14 in AcmA-
LysM1 was mutated to Tyr via a PCR using the Quick Change Site-Directed Mutagenesis
kit (Stratagene) and the following primers: fw, 5’-ACC GTC AAA TCT GGT GAT ACT
CTT TAT GGA ATC TCA CAA AGA TAT and rev, 5’-C ATA TCT TTG TGA GAT
TCC ATA AAG AGT ATC ACC AGA TTT GAC GG. The PCR product was treated
with the restriction enzymes NcoI and XhoI and ligated into a nisin inducible expression-
secretion vector derived from pNZ8048 [84], resulting in plasmid pPD600 (Table 1).
The DNA sequences for four single Trp mutants of the AcmA-LysM1 domain, in-
cluding a spacer at the N-terminal end, were chemically synthesized. Trp14 was replaced
by Tyr and a Trp codon was introduced at corresponding codon positions of amino acid
residues 5, 15, 20, and 39, respectively. Each synthetic fragment was fused, using Esp3I
and HindIII restriction sites, to the 3’ end of the Trp-less AcmA-LysM1 gene in plasmid
pPD600, yielding four single Trp LysM tandem constructs (Figure 2.7).
The double Trp LysM tandem, containing two fused AcmA-LysM1 motifs, each har-
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bouring Trp14, was created as described previously [71].
Electrotransformation of Trp auxotroph L. lactis strain PA1002 [54] was carried out
as described previously [85] using a Bio-Rad Gene Pulser (Bio-Rad). Nucleotide sequence
analysis and DNA synthesis were performed by BaseClear (Leiden, The Netherlands).
2.3.4 Expression of LysM tandem constructs
L. lactis Trp auxotroph strain PA1002, harboring the plasmid containing the gene
of the LysM tandem construct, was grown overnight in GM17 broth (M17, Oxoid) sup-
plemented with 0.5% (w/v) glucose and 5 µg/ml of chloramphenicol at 30 ◦C [86]. Sub-
sequently, fresh GM17 with 5 µg/ml of chloramphenicol was inoculated (1:20) with the
overnight culture and grown until an OD600 of 0.8 was reached. The cells were harvested
by centrifugation at 8.000 × g for 10 min at 30 ◦C, washed three times with PBS, and
resuspended in 50 ml CDM (chemically defined medium) [87], supplemented with 0.5%
(w/v) glucose and 1 mM of all amino acids, except Trp. After a starvation period of 30
min at 30 ◦C, nisin and 1 mM 7AW or 5HW was added as described [54]. The cells were
subsequently incubated for 18 h at 30 ◦C.
2.3.5 Protein purification
The LysM tandem protein (20.1 kDa) is secreted and it is the most abundant protein
in the culture supernatant. After centrifugation, ammonium-sulphate (AS) was added to
the culture supernatant to 30% saturation, and the pH was adjusted to 7.1. This solution
was loaded on a 5 ml HiTrap Phenyl HP column (GE Healthcare) and washed with 5
column volumes of 30% AS in 50 mM Na-Phosphate buffer, pH 7.1, using FPLC (A¨kta
fplc, Uppsala, Sweden) at 4 ◦C and a flow rate of 1.5 ml/min. The LysM tandem protein
was eluted using a 15 ml gradient from 30% to 0% AS saturation in 50 mM Na-Phosphate
buffer, pH 7.1. Fractions containing the protein of interest were dialyzed against 100
mM Na-Phosphate buffer, pH 7.1 at 4 ◦C. The protein purity was > 95% according to
SDS-PAGE analysis. Protein concentrations were determined using a Bradford assay with
BSA as standard.
2.3.6 Fluorescence
Steady-state fluorescence spectra were recorded with a Fluorolog-3 fluorimeter (In-
struments S.A. Inc., Edison, New Jersey, USA). A protein concentration of 0.5 µM in 125
µl PBS buffer (pH 7.4) was used. The 7AW- and 5HW-containing proteins were excited
at 305 nm or 310 nm, respectively. Excitation and emission slits were set at 1.25 nm
and 4 nm, respectively, and 3 × 3 mm quartz cuvettes were used. Fluorescence emission
was measured from 320 nm to 500 nm at 23 ◦C. All spectra were corrected for buffer and
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instrument response. Spectra were recorded two or three times, and the variation between
the integral values were found to be less than 5%.
2.3.7 Modelling and computational docking of an AcmA LysM
motif
The program ”WhatIf” [88] was used to generate a structural model of AcmA-LysM1,
using an alignment with the sequence of the second LysM motif of MltD from E. coli
(MltD-LysM2) of which the structure has been solved by NMR spectroscopy [63].
The program AutoDock 3.05 [89] was used to predict the location of the binding site
of AcmA-LysM1 using GlcNac-MurNac-Ala (N-acetyl-D-glucosamine-N-acetyl-muramic
acid-Alanine) as a flexible ligand with 19 rotatable bonds. The following local-global
alignment (LGA) parameters were used: initial population = 50; maximum number of
energy evaluations = 5 × 106; maximum number of generations = 27,000; The GridBox-
size (100 × 100 × 100), and grid point spacing (0.350 A˚) were chosen such that the entire
AcmA-LysM1 structural model fits in the GridBox.
2.3.8 Enzyme-linked immunosorbent assay (ELISA)
BLPs were washed in coating buffer (100 mM NaHCO3, pH 9.6), and suspended
to 2.5 × 109 particles per ml. Purified PG was diluted in coating buffer to 100 µg/ml.
Hundred µl aliquots of the BLP suspension, or the PG solution, was added to the wells
of a polystyrene ELISA plate. The plate was incubated overnight at 37 ◦C; unsealed
when BLPs were coated and sealed when PG was coated. The wells were blocked by
incubation with 1.5% gelatin in 1% Tween in Tris buffered saline (TTBS) for 1.5 hours at
37 ◦C, and subsequently washed with TTBS. Fifty µl of LysM tandem construct solutions,
with concentrations ranging from 1 × 10−4 to 1 × 10−1 mg/ml, were added followed by
incubation for 2 hours at 37 ◦C, and subsequently washed with TTBS. Hundred µl of 2,500
times diluted myc antibody, labelled with horseradish peroxidase was added followed by
a 2 h incubation, two washing steps with TTBS, and a single washing step with 100
mM Na-acetate buffer pH 5.0. For detection, a 100 µl solution containing 1 mg/ml o-
phenylenediamine, and 1% H2O2 was used. After 5-30 min, the reaction was stopped by
adding 50 µl of 1M H2SO4. The absorbance was measured at 410 nm.
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2.4 Results
2.4.1 Molecular modelling of a LysM motif of AcmA
The 3D structures of the AcmA LysM motifs from L. lactis have not been determined.
However the structures of LysM motifs from two prokaryotes have been reported, the B.
subtilis YkuD LysM domain [61] and the E. coli MltD LysM motif (MltD-LysM2) [63].
The overall sequence identity between AcmA-LysM1 and MltD-LysM2 is 30% (Figure
2.1) and this structure was used to build a model of AcmA-LysM1. The genome sequence
of L. lactis IL1403 has been reported and contains, besides AcmA, three other genes
encoding cell wall hydrolases with an active site homologous to that of AcmA: acmB,
acmC and acmD. AcmD shows the highest sequence homology to AcmA [90] and the
sequence of all three AcmD-LysM motifs, the MltD-LysM2 motif and the three AcmA
LysM sequences were used in an alignment. The alignment revealed a well known highly
conserved sequence, Gly10-Asp11-Tyr12-Leu13, in the AcmA LysM motifs, as well as a
number of conserved hydrophobic residues (Figure 2.1). Asp11 is conserved in most of
the LysM motifs, and it has been proposed that it interacts with ligand [55]. The results
presented in figure 2.1, combined with the MltD structure, resulted in a model of the
AcmA-LysM1 structure presented in figure 2.2.
2.4.2 In silico docking with carbohydrate substrate
Computational flexible docking techniques have been used to successfully predict
protein-carbohydrate interactions [91, 92]. The computer program AutoDock is capable
of automated docking of a flexible ligand to a nonflexible macromolecular target of known
structure [93, 94]. Bacterial PG consists of chains of GlcNac-MurNac disaccharide repeats.
The polysaccharide chains are interconnected with a peptide bridge attached via the
MurNac moiety. A part of this repeating structure, the GlcNac-MurNac disaccharide
with the first alanine residue of the peptide bridge, GlcNac-MurNac-Ala (N-acetyl-D-
glucosamine-N-acetyl-D-muramic acid-alanine) was used in a flexible docking procedure
to predict the potential binding site(s) of the AcmA LysM domain. The three energetically
most favourable docking results resulting in final docked energies close to -11 kcal/mol
are shown in figure 2.3. The docking results suggest that the region containing the first
α-helix and also the loop after the first β-sheet (Figure 2.2) are important for substrate
binding, possibly at both sides. This prediction is in good agreement with the position of
the binding site of MltD-LysM proposed by Bateman and Bycroft [63], Ohnuma et al. [66]
and Leonardus et al. [65]. The docking model presented in figure 2.3 served as basis to
design single Trp mutants of AcmA-LysM1 by selecting residues Tyr5, Gly15, and Tyr20
which are close to the putative binding site. Tyr39 was also changed to Trp because it is
at a distant position from the putative binding groove. According to the docking results
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Figure 2.1: Alignment of the amino acids sequences of all three LysM motifs of
AcmA (L. lactis MG1363), all three LysM motifs of AcmD (L. lactis IL1403) and
the second LysM motif of MltD (E. coli). The secondary structure (  = beta-sheet,
= alpha-helix) and the consensus sequence (h = hydrophobic, p = polar, a = aromatic) are
indicated below the alignment. In the alignment, amino acids are shaded for similarity (yellow =
polar; green = hydrophobic; light green = aromatic; blue = positively charged; red = negatively
charged; purple = Gly).
Figure 2.2: NMR structure of MltD-LysM2 of E. coli [63] (Left panel) and the 3D
model of AcmA-LysM1 (right panel). N- and C- termini,  helixes, and  strands are
highlighted in the structure of MltD-LysM2 and the model of AcmA-LysM1.
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Figure 2.3: Putative binding site of GlcNac-MurNac-Ala to AcmA-LysM1 according
to in silico docking experiments (left panel - front view; right panel - back view).
The three energetically most favourable docking results with GlcNac-MurNac-Ala as substrate
are presented. Color codes of the amino acids at the surface: yellow = polar; gray = hydrophobic;
blue = positively charged; red = Asp31 (only negatively charged residue present). Locations of
the residues mutated to Trp in this work are indicated by white arrows.
we expect that the microenvironment of Trp39 does not change upon ligand binding and
this mutant can serve as negative control.
2.4.3 Enzyme-linked immunosorbent assay for monitoring bind-
ing properties of LysM tandems
Only two of the three LysM motifs of the AcmA LysM domain are needed for cell wall
binding. The AcmA LysM domain harboring all three LysM motifs gave only a slightly
higher binding a nity [69] An ELISA was developed to test the functionality of the single-
Trp LysM tandems. In this assay we take advantage of an epitope tag (c-myc) introduced
at the N-terminus of the LysM tandem construct (supplementary gure 1.7). A nity
constants for the BLPs or puri ed cell walls and LysM tandem protein interaction cannot
be generated (i) because of the nonuniform composition of the ligands and (ii) because
BLPs and puri ed cell wall molecules, containing a large number of hexosamine units,
can potentially bind more than one LysM tandem protein, so that no conclusion can be
drawn about the stoichiometry of the interaction.
Wells of polystyrene ELISA plates were coated with BLPs or puri ed cell walls.
2.4 Results 29
Figure 2.4: Detection of the binding anity of 7AW-labelled LysM tandem mutants
via ELISA assay. Wells were coated with (A) BLPs or (B) PG.  wild-type double LysM
tandem; - - - W5 LysM tandem; -   - W15 LysM tandem;    W20 LysM tandem and -  - W39
LysM tandem.
Next, the LysM tandem was introduced in the wells and after washing, LysM tandems
bound to the substrate were detected using monoclonal anti c-myc antibodies labelled
with horseradish peroxidase. When ELISA plates were coated with 2.5  109 BLPs/ml,
or 100  g/ml puri ed cell walls, a linear response was measured at 410 nm when 0.01
- 0.1 mg/ml LysM tandem proteins were used. Results of these ELISAs showed that
all single Trp LysM tandems retained their functionality, but exhibited a lower binding
a nity towards BLPs and puri ed cell walls compared to the double Trp LysM tandem
that contains a Trp at the wild type position (Figure 2.4). The lowest binding a nity was
observed for the W15 and W20 LysM tandems, whereas the W5 and W39 LysM tandems
show only a slightly lower binding a nity toward BLPs and puri ed cell walls compared
to the double Trp LysM tandem. The observed di erences in binding a nity indicate that
the engineered positions in single Trp LysM tandems have an e ect on ligand binding.
Due to the limited LysM solubility in the used bu er, we were not able to saturate all
binding sites.
2.4.4 Monitoring interactions between LysM tandems and BLPs
via uorescence
7AW was incorporated into the W5, W15, W20, and W39 single-Trp LysM tandems,
using a published protocol known to result in >95% 7AW incorporation e ciency [54].
Similarly, the W15 and W20 LysM tandems and the double Trp LysM tandem constructs
were labelled with 5HW. For unknown reasons the W5 and W39 LysM tandems could
not be well expressed in the presence of 5HW. The puri ed LysM tandems were titrated
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Figure 2.5: Fluorescence experiments with W20 LysM tandem.
(A) Fluorescence spectra of W20 LysM tandem labelled with 7AW in the presence of various
amounts of BLPs ( 0; - - - 2  106;    4  106; -  - 7  106 and -   - 1  107 BLPs).
(B) Fluorescence spectra of W20 LysM tandem labelled with 5HW in the presence of various
amounts of BLPs ( 0; - - - 2  106;    4  106; -  - 7  106 and -   - 1  107 BLPs).
(C) Dependence of the uorescence intensity of 7AW labelled LysM tandems to binding of BLPs
( W5 LysM tandem; -  - W15 LysM tandem; - - - W20 LysM tandem and    W39 LysM
tandem).
(D) Dependence of uorescence intensity of 5HW labelled LysM tandems to binding of BLPs (
w.t. double LysM tandem;    W5 LysM tandem; - - - W20 LysM tandem).
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Figure 2.6: Titration curves of 5HW labelled W20 single Trp LysM tandem titrated
with BLPs (A) or PG (B).
with BLPs to study the suitability of the Trp analogue to monitor the binding of ligand.
Dierent amounts of BLPs (2  106 to 107 particles) were mixed in solution with 1.25  g
of LysM tandem. Upon introducing 107 BLPs in the solution, the uorescent intensity
decreased 15%, 20%, and 25% for the 7AW labelled W5, W15, and W20 LysM tandems,
respectively (Figure 2.5). The uorescent signal of W39 LysM tandem labelled with 7AW
did not change signi cantly (  3%) when mixed with BLPs. Of all 7AW and 5HW labelled
LysM tandems investigated, the emission intensity of the 5HW labelled W20 LysM tandem
and the double Trp LysM tandem showed the highest sensitivity for BLP binding (35%
change when 107 BLPs were used). When the W20 single Trp LysM tandem labelled with
either 7AW or 5HW was thermally inactivated before the titration experiment (30 min at
100 C), only a 3 - 5% change in uorescence was observed. This experiment con rmed
that the change in uorescence correlates to LysM-BLP binding events and is not caused
by an unspeci c quencher present in BLP. The 3D structures of the investigated LysM
tandem proteins are not known; therefore, it is not possible to explain at the molecular
level the mechanism of the observed changes in uorescence intensity on ligand binding.
The emission maximum of all four 7AW labelled single Trp LysM tandems is 388
 1 nm, and of the three 5HW labelled LysM tandems 334  1 nm. These emission
maxima are typical for 7AW or 5HW exposed at the protein surface [32]. Indeed, in our
AcmA-LysM1 model these labelled positions are predicted at the protein surface (Figure
2.3).
The binding capacity of a LysM tandem towards BLPs and puri ed cell walls can
also be measured by taking advantage of the intrinsic uorescence properties of the LysM
tandem. The uorescence intensity became stable when > 2.5  107 BLPs were added
to 1.25  g of 5HW labelled W20 LysM tandem in solution, (Figure 2.6A). This result
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showed that under the used conditions 1 µg of LysM tandem (LysM motif concentration
of 1 µM) binds ∼2 × 107 BLPs. This result is in good congruence with a previously
published report stating that 1 µg of AcmA-LysM domain is needed for saturated binding
to 1.7 × 107 BLPs [71]. When the 5HW labelled W20 LysM tandem was titrated with
PG the same fluorescence intensity change was obtained as for BLPs (Figure 2.6). The
similar decrease in fluorescence intensity supports the view that LysM interact with the
PG part of the cell wall. The saturation point was reached when 1.2 µg of PG was added,
corresponding to a binding capacity of 1.2 µg of purified cell walls per 1 µg LysM tandem.
2.5 Discussion
Much progress has been made in understanding the physiological role of the LysM
domains [55]. Still there is limited information available about how LysM domains in-
teract with their ligand. To investigate the LysM structure - function relationship and
the kinetics of the LysM - ligand interaction in more detail, an easy to use and sensitive
methodology is needed to directly monitor the LysM - ligand interaction. In this work such
a methodology is presented, based on the intrinsic Trp analogue fluorescence properties of
LysM. A model of AcmA-LysM1 was generated to find residue positions which are close
to the binding site and could be exchanged to a Trp analogue, allowing monitoring the
ligand-binding event via fluorescence. In the AcmA-LysM1 model Asp11, as part of the
highly conserved GDTL sequence, is located in the loop between β-strand 1 and α-helix 1
(Figure 2.3). It lies at the end of shallow groove on the surface of the domain. This region
was proposed before in MltD-LysM as ligand-binding site [63]. Based on this hypothesis
and the docking results, the Tyr at positions 5 and 20 and Gly at position 15 were sub-
stituted for Trp because they are positioned close to the putative substrate binding site.
In initial experiments, LysM tandem proteins, labelled with Trp, were produced, isolated,
and titrated with purified cell using an excitation wavelength of 295 nm. This induced a
change in emission intensity of the W5, W15, W20, and W39 proteins of up to -16%, -13%,
-25%, and +4%, respectively (data not shown). Thus, the engineered Trp residues near
the putative binding site do report on the ligand-binding event. The high autofluorescence
of BLPs, when excited at 295 nm, prevented a similar titration experiment. BLPs contain
proteins and the autofluorescence of BLPs is much lower when excited at 305 or 310 nm.
Replacing Trp by 7AW or 5HW in the tandem proteins enables monitoring the binding
of BLPs to LysM when excited at 305 or 310 nm. The autofluorescence intensity at the
highest BLP concentration used in this work (2.5 ×107 particles per mL) was more than
10-fold lower than the fluorescence intensity of the 7AW or 5HW-labelled LysM tandem
protein at 0.5 µM. This demonstrates the potential of these analogues when a high Trp
background is present in the solution [22, 95, 36].
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An ELISA test showed that the introduction of Trp analogues at these 3 positions re-
sulted in functional constructs although a lower binding affinity for BLPs and purified cell
walls was measured, suggesting that these residues are involved in substrate binding. The
fluorescence of these 3 constructs changed significantly upon ligand binding. In contrast,
the fluorescence of W39 LysM tandem, in which the Trp is located at a distant position
to the putative binding site, did not change notably upon substrate binding. This mutant
showed a similar ligand binding affinity as the double Trp LysM tandem containing Trp
at the wild-type position. Taking together, the selected residue positions Tyr5, Gly15,
and Tyr20 in the AcmA-LysM1 model can be replaced by a Trp codon allowing efficient
labelling with Trp analogues to detect ligand-binding events in a sensitive way.
The presented fluorescence approach allows the detection of low amounts of ligand,
when 5HW-labelled W20 and the double-Trp LysM tandem proteins are used given that
the fluorescence intensity of these two proteins was found to be the most sensitive for
ligand binding. For example when 1.25 µg of LysM tandem was used, as low as 2 × 106
BLPs can be detected, as this amount of BLPs induced a fluorescence change of ∼10%.
The same change in fluorescence is induced when 0.2 µg of purified cell walls is present in
the solution.
The fluorescence of 7AW is known to be more sensitive for changes in the microen-
vironment than 5HW [78]. We found that the change in emission intensity of the two
5HW-labelled proteins upon ligand binding (Figure 2.5B and 2.5D) is larger than ob-
served for the same proteins labelled with 7AW (Figure 2.5A and 2.5C). At the moment
we have no proper explanation for this observation.
The method reported here can be used to address LysM related issues: (i) to dis-
cover other ligands besides the GlcNAc-MurNAc-Ala unit; (ii) to determine whether the
affinity for LysM is affected by the length of the PG polymer and (iii) to determine the
pre-steady state kinetics of the binding event. In addition, the approach presented in this
work may find application in a biosensor for monitoring the presence of PG or bacterial
cells in turbid solutions, including solutions with a high autofluorescence when excited <
305 nm.
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2.6 Supplementary gures
Figure 2.7: Schematic representation of proteins:(A) N-acetylglucosaminidase (AcmA);
(B) wild type double Trp LysM tandem; (C) W5 LysM tandem; (D) W15 LysM tandem; (E)
W20 LysM tandem and (F) W39 LysM tandem. X - catalytic part of the AcmA; Y - c-myc;
S1-S3 - spacer sequences; M1-M3 - LysM motifs. The Trp positions in the proteins are indicated.
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3.1 Abstract
Biosynthetic incorporation of tryptophan (Trp) analogues in recombinant proteins
using an E. coli Trp auxotroph expression host is limited to analogues modified with a
small substituent like a fluoro atom or a hydroxyl or amine group. We report here the
efficient incorporation (> 89%) of chloro- and bromo- atoms-containing Trp analogues in
alloproteins at high expression levels using a Lactococcus lactis Trp auxotroph strain. This
result was only obtained after coexpression of the enzyme tryptophanyl-tRNA synthetase
of L. lactis (lacTrpRS), an enzyme believed to show a more relaxed substrate specificity
than TrpRS from E. coli. Chloro- and bromo-Trps are attractive intrinsic phosphorescence
probes as these Trp analogues are much less sensitive than Trp for quenchers in the
medium, like oxygen. Coexpression of lacTrpRS was also essential for the biosynthetic
incorporation (94%) of the Trp analogue 5,6 difluoroTrp. This makes our expression
system ideally suited to generate a set of methyl- and fluoro-substituted Trp analogue-
containing alloproteins in high yield for investigating the involvement of the Trp residue
in cation-pi or pi-pi interactions. Taken together, the presented Trp auxotroph expression
system features the most relaxed specificity for Trp analogue structures reported to date
and gives a high alloprotein yield.
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3.2 Introduction
Incorporation of non-canonical amino acids is an attractive strategy for introducing
novel chemical and physical properties in recombinant proteins. For global replacement of
an amino acid for its analogue in a recombinant protein an amino acid auxotroph expres-
sion strain is used, and the expression of alloproteins, proteins containing an unnatural
amino acid, is relatively simple. A high incorporation efficiency of the amino acid ana-
logue is often achieved together with a good alloprotein expression level [96, 97, 98, 99].
Only amino acid analogues which are structurally close to the natural amino acids can be
incorporated in this way, a consequence of the high substrate specificity of the aminoacyl-
tRNA synthetase (aaRS) enzymes. AaRS catalyses the activation of its cognate amino
acid using ATP and its coupling to the corresponding tRNA, yielding aminoacyl-tRNA. In
recent years, several developments to expand the set of non-canonical amino acids which
can be incorporated under in vivo conditions, have been reported. Successful strategies
include rational design of the amino acid binding pocket of aaRS, or coexpression of aaRS
in the expression host [47, 53, 48, 49].
To date, a limited number of tryptophan (Trp) analogues have been biosynthetically
incorporated in proteins, namely mono-substituted fluoroTrps, aminoTrps and hydrox-
yTrp analogues [100, 101, 102, 97]. Incorporating Trp analogues containing a bulkier
substituent in proteins was not successful [103, 22] except in one study where a designed
orthogonal aaRS/tRNA pair was introduced in E. coli, allowing incorporating 6-chloroTrp
(6ClW) and 6-bromoTrp (6BrW), but not 5-bromoTrp (5BrW), at an amber codon posi-
tion in the gene of the target protein [104]. This is an attractive strategy to label proteins
[50]; however, development of an orthogonal aaRS/tRNA pair is not trivial and typically
a low alloprotein yield is obtained.
Recently we reported the use of a L. lactis Trp auxotroph as host to incorporate
Trp analogues, including 5-methylTrp (5MeW) [54], a Trp analogue not translated by E.
coli [103]. This result suggests that the substrate specificity of L. lactis tryptophanyl-
tRNA synthetase (lacTrpRS) is more relaxed than E. coli tryptophanyl-tRNA synthetase
(ecoTrpRS).
In this report, we present an approach to increase the number of Trp analogues which
can be incorporated efficiently by L. lactis (Figure 3.1). To achieve this, lacTrpRS was
co-expressed together with the recombinant target protein. We show here that coexpres-
sion of lacTrpRS into the L. lactis Trp auxotroph results in efficient incorporation (89%
- 97%) of all investigated Trp analogues in recombinant proteins together with a high
expression levels.
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Figure 3.1: Structures of tryptophan and its analogues used in this study: Trp - tryp-
tophan; 5FW - 5- uorotryptophan; 5HW - 5-hydroxytryptophan; 5MeW - 5-methyltryptophan;
5,6diFW - 5,6-di uorotryptophan; 5BrW - 5-bromotryptophan; 6ClW - 6-chlorotryptophan;
6BrW - 6-bromotryptophan
3.3 Materials and methods
3.3.1 General DNA techniques and transformation of L. lactis
Standard recombinant DNA techniques were performed as described previously [83]
or as speci ed by the manufacturers. Enzymes and bu ers were purchased from BioLabs -
New England or Roche. Nucleotide sequence analysis and DNA synthesis were performed
by BaseClear (Leiden, The Netherlands).
The trpRS gene encoding tryptophanyl-tRNA synthetase was ampli ed from L. lactis
MG1363 chromosomal DNA via PCR using pFU Taq DNA polymerase and the follow-
ing primers: trpRSfw (5 -AAAGAGCTCAAAGGAGAAAAAAATGACAAAA CC) and
trpRSrev (5 -AAACTGCAGAGGTGTCAAAACAATGAATTACC) containing SacI and
PstI restriction sites, respectively. The ampli ed fragment was puri ed using a PCR pu-
ri cation kit (Qiagen) and subsequently cloned into the pMG36e expression vector [105],
using SacI and PstI restriction enzymes and T4 DNA ligase, yielding plasmid pMG36e-
trpRS.
Plasmid pPA295, containing the W20LysM tandem gene [106], was derived from
a nisin inducible expression-secretion vector pNZ8048 [84], and electrotransformed into
freshly prepared electrocompetent L. lactis PA1002 cells harboring the pMG36e-trpRS
plasmid using a Bio-Rad Gene Pulser (Bio-Rad) [85].
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3.3.2 Chemo-enzymatic synthesis and purification of tryptophan
analogues
5-hydroxyTrp (5HW), 5MeW and 5BrW were from Sigma-Aldrich. 5-fluoroTrp (5FW),
5,6-difluoroTrp (5,6diFW), 6ClW and 6BrW were synthesized using a modified published
procedure [107]. In brief, 17.5 mol acetic acid, 1.8 mmol acetic anhydride, 0.4 mmol of
L-serine (Acros Organics) and 0.2 mmol of indole analogue, 5F-indole (Sigma-Aldrich),
5,6diF-indole (Biosynth), 6Cl-indole (Biosynth), or 6Br-indole (Biosynth), respectively,
were mixed and the solution deaerated via purging with argon gas. This solution was in-
cubated for 3 h at 73 ◦C. Subsequently, 10 ml of sodium-borate buffer, pH 8.0, containing
0.125 mM cobalt(II)-chloride was added to the reaction mixture, and the pH was adjusted
to 8.0 with NaOH. Amano-acylase from Aspergillus niger (Sigma-Aldrich) was added at
a concentration of 10 mg/ml, and the solution incubated for 48 h at 37 ◦C with shaking
(250 rpm). The solution was centrifuged for 10 min at 5,400 × g and the supernatant
was loaded in 2.5 ml portions on a PD-10 Desalting column (Amersham Bioscience), pre-
equilibrated with 10 mM NaOH. Tryptophan analogues were eluted in 2 ml fractions from
the column using 10 mM NaOH. Fractions with the highest A280/A405 ratio were pooled
and concentrated 8 times in a vacuum concentrator (Eppendorf).
The purity of the synthesized Trp analogues were determined via silica-gel thin-layer
chromatography (TLC) with butanol:H2O:acetic acid (4:1:1) as mobile phase. Visualiza-
tion was done in iodine vapor [108].
3.3.3 L. lactis growth, protein expression and purification
Lactococcus lactis Trp auxotroph PA1002 [54], harboring the pPA295 and pMG36e-
trpRS plasmids, was grown overnight at 30 ◦C in GM17 broth (M17 (Oxoid) supplemented
with 0.5% (w/v) glucose) [86], 5 µg/ml of chloramphenicol and 75 µg/ml of erythromycin.
Subsequently, 50 ml fresh GM17 medium with 5 µg/ml of chloramphenicol and 75 µg/ml
of erythromycin was inoculated with this overnight culture (1:50) and growth at 30 ◦C
was continued until an OD600 of 0.8. The cells were harvested by centrifugation at 5,400
× g for 10 min at 30 ◦C, washed three times with PBS at 30 ◦C, and resuspended in 50
ml CDM (chemically defined medium) [87] supplemented with 0,5% (w/v) glucose and 1
mM of all amino acids, except Trp. After a starvation period of 30 min at 30 ◦C, nisin,
1 mM Trp or Trp analogue was added, as described [54]. The cells were subsequently
incubated for 18 h at 30 ◦C.
The LysM tandem protein is secreted by L. lactis and it is the most abundant pro-
tein in the culture supernatant. After centrifugation, the supernatant was loaded on an
Amicon concentrator device (MWCO 3 kDa) and washed with phosphate buffered saline
(PBS), pH 7.4. LysM alloprotein concentrations were determined by comparing the in-
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tensity of the alloprotein bands with BSA as standard via an SDS-PAGE, gel stained with
0.05% Coomassie Brilliant Blue R-250 solution, using GelQuant.NET software provided
by Biochemlabsolutions.
3.3.4 Mass spectrometry
20 µl aliquots of W20LysM tandem protein (≈0.1 mg/ml) in PBS, pH 7.4 was ex-
changed to 100 mM ammonium bicarbonate buffer using an Amicon concentrator (MWCO
3 kDa). 2 µl of a porcine trypsin (Promega) stock solution (55 µg/ml) was added and the
sample was incubated for 3 h at 37 ◦C. 0.75 µl was spotted on a MALDI (matrix-assisted
laser-desorption ionization) target and mixed immediately with an equal volume of 10
mg/ml α-cyano-4-hydroxycinnamate (LaserBio Labs) in 50% acetonitrile / 0.1% (v/v)
trifluoroacetic acid. Spots were recorded on a Voyager DE-PRO MALDI-TOF (time of
flight) instrument (Applied Biosystems). Spectra were calibrated externally with standard
peptides. Noise filter (correlation factor of 0.9) and Gaussian smoothing (filter width of 19
points) were applied to all spectra using Data Explorer (TM) software (Applied Biosys-
tems). The Trp analogue incorporation efficiency was calculated by measuring the peak
areas of the Trp analogue containing peptide and the Trp containing peptide.
3.3.5 Fluorescence
Steady-state fluorescence spectra were recorded with a Fluorolog-3.2.2 fluorimeter
(Jobin-Yvon, Edison, NJ, USA). A protein concentration of approximately 0.1 mg/ml
was used. W20LysM tandem containing 5FW, 5HW and 5MeW, were excited at both
295 nm and 305 nm. Excitation slits were set up at 0.5 nm, emission slits were set at 5.00
nm and 3 × 3 mm quartz cuvettes were used. Fluorescence emission was measured from
320 nm to 450 nm at 23 ◦C. Spectra were corrected for the PBS buffer emission.
3.4 Results
3.4.1 Cloning and overexpression of lacTrpRS
The nucleotide sequence of the genome of the lactic bacterium L. lactis subsp. cre-
moris MG1363 is known (NCBI, GenBank: AM406671.1 http://www.ncbi.nlm.nih.gov/nu
ccore/AM406671) [109] and we identified the trpRS gene in the locus llmg 0079. Using
PCR, a fragment of 1075 base pairs (bp) comprising the trpRS nucleotide sequence (1025
bp) and a putative ribosome-binding site was amplified and cloned into the pMG36e plas-
mid [105] behind the strong constitutive promoter P32 [110]. The newly constructed
plasmid, pMG36e-trpRS, was transformed into the L. lactis PA1002 Trp auxotroph strain
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Figure 3.2: Expression of lacTrpRS recombinant pro-
tein in L. lactis PA1002, visualized via a 12.5% SDS-
PAGE Lane 1: L. lactis PA1002 harboring lacTrpRS encoding
plasmid (black arrow indicate lacTrpRS band). Lane 2: L. lac-
tis PA1002 harboring empty pMG36e plasmid
[54].
SDS-PAGE analysis of protein extracts of these cells harvested at OD600 0.7
revealed the presence of a protein band at approximately 38 kDa (theoretical mass of
lacTrpRS is 37963 Da). This band was not visible in a control experiment (Figure 3.2).
This experiment demonstrated that lacTrpRS enzyme is well overexpressed in L. lactis,
before the induction of the target protein is initiated.
3.4.2 Biosynthetic incorporation of Trp analogues into the W20LysM
tandem protein
The L. lactis Trp auxotroph strain PA1002, harboring plasmid pMG36e-trpRS, was
transformed with the plasmid encoding the single-Trp-containing target protein, W20LysM
tandem [106]. The W20LysM tandem and the lacTrpRS containing plasmids comprise dif-
ferent promoters, P32 - constitutive promoter [105] and PnisA - nisin inducible promoter
[111], respectively, and dierent selection markers, the genes for chloramphenicol and
erythromycin resistance, respectively. Expression of the W20LysM tandem protein was
performed in CDM supplemented with 1 mM Trp, or Trp analogue. Excellent expression
levels of W20LysM tandem alloproteins were observed in all cultures (25 - 50 mg per 1 l
of culture). Only in the presence of 5BrW or 6BrW slightly lower expression levels were
observed (Figure 3.3). The high yield of alloproteins containing 5HW, 5,6diFW, 6ClW,
5BrW and 6BrW is due to the coexpression of lacTrpRS. When L. lactis PA1002 con-
tains only W20LysM tandem-containing plasmid very low or no detectable expression of
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Figure 3.3: SDS-PAGE of
culture supernatants af-
ter overnight expression of
W20LysM tandem in the
presence of Trp or a Trp
analogue. W20 LysM tandem
expressed in the presence of:
Lane 1: Trp; Lane 2: 5FW; Lane
3: 5HW; Lane 4: 5BrW; Lane 5:
5MeW; Lane 6: 5,6diFW; Lane 7:
6ClW; Lane 8: 6BrW
Figure 3.4: SDS-PAGE of culture supernatants of L. lactis coexpressing lacTrpRS
[+] or without coexpressing lacTrpRS [-]. Samples were collected after overnight expression
of W20LysM tandem in the presence of 5HW, 5,6diFW, 6ClW, 5BrW or 6BrW, respectively. MW
is the molecular mass standard.
W20LysM was observed (Figure 3.4). For the 5FW- and 5MeW- containing W20LysM
tandem expression levels were found only minimally dependent on coexpression of lacTr-
pRS (data not shown).
The incorporation e ciency of each Trp analogue in the target protein was established
by MALDI-TOF mass spectrometry. For W20LysM tandem expressed in CDM supple-
mented with Trp, a tryptic peptide with a mass of 1629.67 Da was detected. This intense
peak was absent or its intensity strongly reduced for W20LysM tandem expressed in the
presence of a Trp analogue. In the mass spectra of these samples a new peak was present
corresponding to the mass of the Trp analogue-containing peptide (Figure 3.5). Very high
incorporation e ciencies ( 94%) were found for 5FW, 5HW, 5MeW and 5,6diFW, while
for the other Trp analogues the incorporation e ciency was 90% (Table 1).
W20LysM tandem alloproteins containing 5FW, 5HW and 5MeW show a compara-
ble uorescence quantum yield (Q) as W20LysM tandem containing Trp. The identical
shape of the emission spectra, when excited at 295 nm or 305 nm, supports the view that
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Table 3.1: Trp analogue incorporation effi-
ciency into W20 LysM tandem protein.
the presence of Trp in these three protein samples is very low (Figure 3.6). The fluo-
rescence Q of W20LysM tandem proteins containing 5,6diFW, 5BrW, 6ClW and 6BrW,
respectively, is very low, < 0.01 (data not shown). Such a low fluorescence Q does not
allow accurate comparison of emission spectra of the proteins when excited at 295 nm and
305 nm wavelengths, respectively.
3.5 Discussion
In this work we report an efficient strategy to incorporate Trp analogues including
those not biosynthetically introduced in proteins before, with high incorporation efficiency
and resulting in a high alloprotein yields. The single Trp-containing protein, W20LysM
tandem, was used as target protein for the incorporation of Trp analogues. W20LysM
tandem is a small 20 kDa protein and a 3D model of this protein suggests the Trp residue
is at a surface-exposed position [106]. By choosing a surface exposed Trp position instead
of a buried position minimizes the chance that its replacement with a bulky Trp analogue
(e.g. 5BrW and 6BrW) compromises the folding and stability of the alloprotein.
Initial studies with 5BrW using the L. lactis Trp auxotroph PA1002 as expression
host suggested that this analogue can be incorporated by L. lactis, as a very low amount
of alloprotein was obtained. Cloning of the lacTrpRS behind the constitutive P32 pro-
moter [105] and its coexpression together with the target protein resulted in large increase
in the expression levels of alloproteins containing 5,6diFW, 6ClW, 5BrW and 6BrW, re-
spectively. Expression levels were approximately equal to those obtained with Trp in the
medium (∼50 mg/l); except that the alloproteins containing 5BrW and 6BrW expression
levels were ∼50% lower. 5HW can also be incorporated without lacTrpRS coexpression,
however a lower alloprotein yield (Figure 3.4) and a lower incorporation efficiency (89%
versus 95%) are observed [54]. Similarly, the 5MeW incorporation efficiency increase from
92% to 94% when lacTrpRS was coexpressed.
The new alloproteins, which can now be produced relatively easily, offer novel op-
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Figure 3.5: MALDI-TOF spectra of tryptic peptide of W20 LysM containing Trp or
a Trp analogue. The mass region of the WGISVAQIQSANNLK peptide is shown. The peak of
protonated peptide containing Trp (a), 5FW (b), 5HW (c), 5,6diFW (d), 5MethylW (e), 5BrW
(f), 6ClW (g) and 6BrW (h), respectively, are shown.
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Figure 3.6: Emission spectra of W20LysM tandem al-
loproteins excited at 295 and 305 nm, respectively. Red
line - emission spectrum of W20LysM tandem excited at 295
nm, black line - emission spectrum of W20LysM tandem ex-
cited at 305 nm; (a) 5HW; (b) 5FW; (c) 5MeW containing
W20LysM tandem. Spectra were normalized.
portunities in protein structure and function studies. For example, evaluation of a set
of alloproteins containing a Trp with electron-donating (methyl) or withdrawing (fluoro)
substituents in the indole moiety offer a powerful means to study the role of a Trp residue
in cation-pi or pi-pi interactions [112]. So far, alloproteins used in such studies were pro-
duced in very low amounts via an in vitro methodology using Xenopus laevis oocytes
as expression system. The chloro- and bromo substituted Trp analogues offer interesting
opportunities as intrinsic phosphorescence probes. Trp phosphorescence spectroscopy is
one of the most sensitive methodologies known to probe local viscosity in a protein and is
also ideally suited to investigate if the protein is present in different conformational states
[113, 114]. Widespread use of Trp phosphorescence is limited by the extreme sensitivity of
the triplet state to quenchers, like oxygen [115]. For reliable measurements, the quencher
concentrations in the buffer need to be reduced to the sub-nM concentration range. The
high sensitivity is a result of the very long intrinsic triplet lifetime (6.5 s) of Trp [115],
giving quenchers ”ample time” to deactivate the triplet state. Chloro or bromo substitu-
tion of Trp strongly reduces the intrinsic triplet lifetime [116], making it 1 - 3 orders of
magnitude less sensitive for quenchers like oxygen. Moreover, these substituents enhance
the intersystem crossing rate from the singlet to the triplet state, thus suppressing fluo-
rescence and increasing the phosphorescence intensity. We are currently investigating the
spectroscopic properties of the various alloproteins via phosphorescence methodologies.
In summary, a versatile Trp analogue expression system was developed in L. lactis,
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allowing the efficient biosynthetic incorporation of Trp analogues in proteins not reported
before together with a high alloprotein yield.
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4.1 Abstract
5-Hydroxy-L-tryptophan (5HW) has been biosynthetically incorporated in many pro-
teins to facilitate their characterization using fluorescence spectroscopy. An attractive
feature of this tryptophan analogue is its absorbance at 310-320 nm, allowing its spe-
cific excitation in a Trp background. The red-shift in absorbance upon introduction of a
hydroxyl group at the 5-position of Trp or indole was found to be due to a lowering of
the 1Lb transition energy. It was therefore believed that 5HW only features
1Lb emission
while the 1La state is typically the emitting state for Trp. Recently, calculations for 5-
hydroxyindole (5HI) in water revealed that the 1La is the emitting state, and the same
was predicted for 5HW incorporated in proteins. To clarify which state emits in 5HI and
5HW, we present here excitation anisotropy spectra of these probes and of four proteins
labelled with 5HW at a surface exposed position. Our data clearly show that 1Lb is the
emitting state of 5HI, 5HW and of 5HW in three of the proteins investigated. For one
protein mixed emission was observed, and the decay kinetics were found strongly depen-
dent on the emission wavelength. This work provides the first experimental evidence that
1La can be the emitting state for this Trp analogue incorporated in a protein.
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Tryptophan (Trp) fluorescence spectroscopy is widely used to study protein structure,
dynamics and function [3]. Most information can be extracted when a single-tryptophan-
containing protein is studied. Experimental observables include the quantum yield, spec-
tral energy of the emission, and anisotropy. These observables are related to return of
the excited electron from the lowest electronically excited state of the fluorophore to the
ground state. Trp and Trp analogues have four singlet valence pi - pi* electronic excited
states, the lower energy 1La and
1Lb states and the higher energy
1Ba and
1Ba states
[17]. Only the two 1L states play a role in Trp and Trp analogue fluorescence and their
absorption spectra extensively overlap. The excited-state conversion between the 1La and
1Lb states is known to be extremely fast [117], and the transition dipole moments of the
1La and
1Lb states of indole are nearly perpendicular to each other [118]. In the gas phase
the 1Lb state of indole is 0.3 eV lower in energy than the
1La state [119]. In most media,
1La becomes the lowest excited state, a result of the more efficient stabilization of the
large 1La dipole moment (5 - 6 D) via solute interactions compared to the smaller dipole
moment of the 1Lb state (≈2 D) [120, 119]. 1Lb is the emitting state only for indole in
the gas phase or when dissolved in perfluorohexane [18, 119]. Moreover, three single-Trp-
containing mutants of transhydrogenase domain 1 emit from both the 1Lb and
1La state
[20, 19]. In these proteins, the Trp is embedded in a very rigid and apolar protein core.
Substitution of a hydroxyl group at the 5-position of indole results in a red-shift of the
absorption spectrum. The absorption of the red-extended shoulder of 5-hydroxytryptamine
(serotonin) is due to 1Lb absorption, and
1Lb is the emitting state [121]. Lami reported the
same for 5-hydroxyindole (5HI) [122, 22]. Thus introduction of a hydroxyl group at the
5-position increases the 1La -
1Lb gap [32] and in most publications it is assumed that
1Lb
is the emitting state in 5-hydroxytryptophan (5HW) and 5HI [123, 124, 125, 30]. Dipole
moments of 2.14 D and 2.04 D were calculated for the ground and 1Lb states, respectively,
of 5HI [126] and in accordance with this, a small variation in emission maximum (λmax)
of 5HI in different solvents (cyclohexane λmax = 322 nm; water λmax = 331 nm) is ob-
served compared to the 1La emitting indole (cyclohexane λ
max = 298 nm; water λmax =
342 nm) [122, 22]. Recent theoretical studies challenged the generally accepted idea that
free 5HI dissolved in water, or 5HW incorporated into proteins, show emission from 1Lb
[126, 127]. H-bonding to the 5-hydroxy group was found to decrease the 1La -
1Lb gap
with 1La becoming the emitting state when either one water molecule makes a single long
H-bond with the hydroxy group or if two water molecules make H-bonds with the hy-
droxy group. An experimental study to investigate the fluorescing state of 5HI, 5HW and
5HW-containing proteins has not been presented. Excitation anisotropy spectra of indole
and its derivatives can accurately establish the emitting state and we used this approach
recently to establish the emitting state of the most blue-emitting single-Trp containing
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proteins known, azurin, transhydrogenase domain 1 and mutants of these proteins [20, 19].
Here we use the same approach to establish the emitting state of 5HI, 5HW and 5HW
incorporated in four proteins at a single position. 1Lb was found to be the emitting state
for free 5HI and 5HW and data are presented showing the protein matrix can promote
the 1La state to become emitting, as dual emitting was observed for 5HW in one of the
proteins investigated.
4.3 Materials and methods
4.3.1 Materials
5-Hydroxy-L-tryptophan (5HW) was purchased from Sigma-Aldrich, 5-hydroxyindole
was from TCI, and glycerol (spectroscopic grade) was from Merck.
LysM tandem proteins. Biosynthetic incorporation of 5HW in single Trp mutants of
the LysM tandem protein and its purification were done as described in detail before [128].
This protocol results in a 95% incorporation efficiency of 5HW in LysM tandem protein.
4.3.2 Spectroscopy
Fluorescence spectra were recorded with a Fluorolog 3-22 fluorospectrometer (Jobin
Yvon) equipped with Glan-Thompson polarisers in L-format. Excitation slit widths of
3 nm were used for 5HW and 5HI and 5 nm for LysM tandem protein experiments.
Band passes of 3 nm were used for 5HW and 5HI and 5 nm for LysM tandem protein
experiments. The emission band passes were at 5 nm. Steady state excitation and emission
spectra were recorded with emission monitored at 340 nm and excitation at 295 nm,
respectively, and the spectra were corrected for instrument response. Low-temperature
spectra were recorded with a quartz Dewar set up and a quartz tube (r = 2.5 mm). Solid
CO2 was added to 99 % ethanol and used to cool the sample to -50
◦C. Glass samples were
prepared by mixing 5HI, 5HW, or 5HW-containing LysM tandem protein in phosphate
buffered saline (PBS) pH 7.4 with glycerol (30:70 (v/v)). The final concentration of 5HW,
5HI and LysM tandem containing 5HW were 6-30 µM.
Time resolved emission detection was performed by a streak camera system equipped
with a spectrograph (Hamamatsu C5680, Chromex 250 mm). Excitation was at 300 nm
and the time resolution was 200 ps. Data was analysed using a standard Levenberg-
Marquardt fitting method [129].
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We started our investigation by collecting data for free 5HW, 5HI, and 5HW-labelled
single-Trp W20LysM tandem protein. This protein of 20 kDa shows a high binding affin-
ity for peptidoglycan and a Trp codon was introduced at residue position 20 allowing
monitoring peptidoglycan binding via Trp analogue fluorescence spectroscopy [106].
The λmax values of free 5HI, 5HW and the alloprotein in a glycerol glass at -50 ◦C
are at 328 nm, 335 nm, and 336 nm, respectively, and anisotropy excitation spectra were
recorded by collecting emission at 320 nm, 340 nm, and 360 nm, respectively (Figure 4.1
and Figure 4.5).
For free 5HW all three recorded spectra are similar in shape; thus the fluorescence
of 5HW at the 3 wavelengths is the same. In line with this observation, r0 was found
essentially independent of the emission wavelength (Figure 4.2A). The gradual increase of
r0 with increasing excitation wavelength (λex) is expected for
1Lb as emitting state as it
dominates the absorbance spectrum at the red-edge of 5HW. The equation
r0λ = fa(λ)r0a + fb(λ)r0b
is needed for resolving the individual 1La and
1Lb spectra of 5HW. r0λ is the observed
anisotropy at wavelength λ and r0a and r0b are the limiting anisotropies of the
1La and
1Lb states at wavelength λ, respectively. fa(λ) and fb(λ) are the fractional contributions
of the 1La and
1Lb transition states at wavelength λ with fa(λ) + fb(λ) = 1 [3]. As red
edge excitation of 5HW only yields 1Lb emission (fa(λ) = 0)[122, 123], r0=r0b. From figure
4.1A it follows that r0 = r0b = 0.35, a value significantly higher than reported before for
5HW (r0 = 0.25) [100], but the same value as obtained for 5-methoxytryptophan [130].




with r0 = 0.35 and β the angle in space between the
1La and
1Lb transient absorption
dipole moments [3]. For β = 0◦, 45◦, and 90◦, this yields r0A values of 0.35, 0.0875 and
-0.175, respectively. The negative r0 values presented in figure 4.1A at λex < 285 nm
indicate that a large β value exist in 5HW. At λex < 285 nm, the excitation spectrum
of 5HW is dominated by 1La and its excitation is followed by rapid transfer to the lower
lying 1Lb emitting state. The contributions of
1La and
1Lb to the excitation spectrum of
5HW at wavelength λ, can be calculated using equations:
Ia(λ) = fa(λ) · I(λ)
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Ib(λ) = fb(λ) · I(λ)
where Ia(λ) and Ib(λ) are the intensities of the excitation spectra of
1La and
1Lb, respec-
tively, at wavelength λ. β values between 0◦ to 66◦ result in negative 1La amplitudes
(data not shown); thus, β values are too small as negative excitation amplitudes are not
acceptable. β values between 67◦ - 90◦ give subspectra with positive amplitudes and these
spectra are presented in figure 4.6B for β = 90◦ and figure 4.6A for β = 67◦. The spectra
are very similar to the two published subspectra of 5-methoxytryptophan (β = 90◦) [130].
Both 1La spectra peak at 270 ±3 nm and do extend far into the red-edge of the 5HW
and 5-methoxytryptophan excitation spectra, respectively. The two 1Lb spectra show the
lowest transition energies in these two Trp analogues. Analysis of the 5HI data in a similar
way (r0 = 0.34, β = 90
◦) gave 1La and 1Lb spectra alike the spectra obtained for 5HW
and with 1Lb showing the lowest transition energy (Figure 4.3B). Only β values of 66
◦ -
90◦ gave subspectra with positive amplitudes (Figure 4.7).
In 5HW-labelled W20LysM tandem protein, 5HW at residue position 20 is predicted
to be surface exposed [106] and anisotropy excitation spectra of this protein, recorded us-
ing the same condition as for 5HW and 5HI, are shown in figure 4.1B. The three recorded
spectra differ in shape with only the spectrum collected at 360 nm showing a similar
shape as for free 5HW and 5HI. For the spectrum collected at 320 nm, r0 at λex < 285
nm is much higher than that for free 5HW but r0 drops sharply at λex > 285 nm. The
relatively high fa(λ) < 285 nm, together with a high r0 in this part of the spectrum is
in agreement with 1La emission collected at 320 nm. The strong increase in r0 at λex
> 292 nm together with an increase in fb(λ) shows
1Lb emission is also occurring at 320
nm. Thus 5HW-labelled W20LysM tandem shows a mixed emission at 320 nm. For the
excitation anisotropy spectrum collected at λem = 340 nm, the contribution of
1La emis-
sion is less than at 320 nm as only a small dip in r0 is observed at λex = 285 - 292 nm.
The excitation anisotropy spectrum collected at 360 nm does not show evidence for 1La
emission occurring in this part of the emission spectrum. The dependence of r0 on the
emission wavelength at 3 of the 4 different λex investigated (Figure 4.2B) is in accordance
with mixed emission for this sample. For λex = 305 nm, r0 is minimally dependent on the
emission wavelength, a result consistent with only 1Lb emission is generated at this wave-
length. Taken together, the anisotropy data of 5HW-labelled W20LysM tandem provide
for the first time experimental evidence for mixed emission of this Trp analogue.
1La emission is centred at the blue part of the emission spectrum of W20LysM tan-
dem protein, while at the red part of the emission spectrum only 1Lb emission is observed.
The calculated excited dipole moments of the 1La and
1Lb states of 5HI are 6.51 D and
2.04 D, respectively [126]. As the emission was collected in a glass, full spectral relaxation
is not possible under these conditions, unlike in fluid medium. This explains why the 1La
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Figure 4.1: Anisotropy excitation spectra of free 5HW (A) and 5HW containing
W20 LysM tandem (B) in a glycerol glass at -50 ◦C. Emission was recorded at 320 nm
(blue), 340 nm (black) and 360 nm (red).
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Figure 4.2: Emission wavelength dependence of the anisotropy of free 5HW (A)
and 5HW containing W20LysM tandem (B) in a glycerol glass at -50 ◦C.Excitation
wavelengths of 260 nm (square), 275 nm (circle), 290 nm (triangle), 305 nm (diamond) were used.
transition, centred at the blue part of the absorbance spectrum of 5HW, is also observed
at the blue part of the emission spectrum.
4.4.1 Time-resolved fluorescence analysis of 5HW- and 5HW-
labelled W20LysM tandem protein
5HW dissolved in water at pH 7 shows a single-exponential fluorescence decay [22],
but when incorporated into proteins it typically shows two or three lifetimes, with values
varying from less than 0.1 ns to 5 ns [37].
A streak camera was used to study the fluorescence decay kinetics of free 5HW and
5HW containing W20LysM tandem protein at emission wavelengths 320 nm, 340 nm, and
360 nm and the results are presented in table 1 and in figure 4.8.
For free 5HW at all three emission wavelengths the decay shows a single lifetime of 3.5
ns, a result congruent with previous reports [30, 31, 131]. The decay of 5HW containing
W20LysM tandem protein is best described by two exponentials, and the decay times are
dependent on the emission wavelength (Table 1). The average lifetime, with individual
lifetime contributions between 0.5 ns and 3.5 ns, increases with changing the emission
wavelength from the blue to the red part of the spectrum. At 360 nm, the 3.5 ns lifetime









5HW 320 3.517 100 — — 0.938
5HW 340 3.493 100 — — 1.09
5HW 360 3.504 100 — — 1.138
5HW-
W20LysM
320 0.526 29 2.982 71 0.965
5HW-
W20LysM
340 1.036 26 3.12 74 0.998
5HW-
W20LysM
360 1.099 35 3.50 65 1.135
Table 4.1: Fluorescence decay parameters of free 5HW and 5HW containing W20 LysM tandem.
This shorter lifetime could be due to 1La emission, appearing at this wavelength because
the data were collected at fluid medium, shifting the 1La emission to red wavelengths
compared to the glass conditions presented in figure 4.2. However this short lifetime can
also be a result of 1Lb emission of a W20LysM tandem protein fraction in a quenched
state. Overall, the strong dependence of the average lifetime on the emission wavelength
is in agreement with mixed emission in 5HW labelled LysM proteins.
4.4.2 Emitting state of 5HW in three other single-Trp mutants
of LysM tandem protein
5HW was also biosynthetically incorporated at positions 5, 15, and 39, respectively,
of three other single Trp containing LysM tandem proteins. Like residue position 20,
these three positions are at the protein surface [106]. Excitation anisotropy spectra of
these three proteins, collected at emission wavelengths 320 nm, 340 nm, and 360 nm, are
presented in figure 4.4. Following the same interpretation as presented above for 5HW,
5HI, and W20LysM tandem protein, all spectra presented in figure 4.4 are typical for only
1Lb being the emitting state at the three investigated emission wavelengths.
4.5 Discussion
In this work we identified the emitting state of 5HI and 5HW, and of 5HW introduced
in four mutants of the LysM tandem protein. The recorded excitation anisotropy spectra
of these samples show that 1Lb is the emitting state in 5HI, 5HW, and in 3 of the 4
proteins investigated. For the W20LysM tandem protein, mixed emission was observed
56
Emitting state of 5-hydroxyindole, 5-hydroxytryptophan and 5-hydroxytryptophan
incorporated in proteins
Figure 4.3: Fluorescence excitation spectra (square) of free 5HW (A) and 5HI (B)
in a glycerol glass at -50 ◦C and their resolved 1La (triangle) and 1Lb (circle)spectra
for β = 90◦.
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Figure 4.4: Anisotropy excitation spectra of 5HW containing proteins W5LysM tan-
dem (A), W15LysM tandem (B) and W39LysM tandem (C), respectively, in a glycerol glass at
-50 ◦C. Emission was recorded at 320 nm (square), 340 nm (circle) and 360 nm (triangle).
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and in accordance with this, the fluorescence decay kinetics of this sample was found
to be emission wavelength dependent. This work was motivated by disparate views in
the literature on the emitting state of free 5HW and of 5HW-containing proteins. For
approximately 20 years, 5HW has been biosynthetically incorporation into proteins, and
its fluorescence has been employed to study protein structure [30, 31]. 5HW is known
as an attractive, intrinsic optical probe of proteins, because of its red-shifted absorbance
spectrum, compared to Trp, allowing its specific excitation at 310-320 nm. The high r0
upon excitation at these wavelengths makes 5HW ideally suitable for anisotropy studies
[30, 31]. Based on several studies [122, 32] it was accepted that in 5HW and 5HI, 1Lb
is the emitting state, while 1La is typically the emitting state in Trp and most other
Trp analogues characterized to date. However, Hirst and coworkers recently reported
the 1La state of 5HI in aqueous solution is the emitting state [126]. In this work, 10 ps
snapshots of MD simulations of 5HI in water at 300 K were used in TDDFT calculations
to generate the 1La and
1Lb absorption spectra of 5HI, and these spectra were compared
with the experimental absorption spectrum. The calculated 1Lb spectrum peaks at 297
nm - the same position as in the absorption spectrum (298 nm) [126]. The 1Lb spectrum
of 5HI, resolved from polarization experiments, also peaks at 298 nm (Figure 4.3B). The
calculated 1La spectrum shows a peak at 286 nm, while the experimental peak is at
274 nm [126]. Also the resolved 1La spectrum in figure 4.3B peaks at 274 nm. Thus the
calculations yielded an 1La spectral peak at much lower energy than given by the available
experimental data. This likely explains why also the 1La origin of the 5HI spectrum was
found at lower energy than the 1Lb origin, leading to the conclusion that
1La is the
emitting state in 5HI. The excitation anisotropy spectrum of 5HI (and 5HW) presented
in this work clearly demonstrates that 1Lb is the emitting state. Also three of the four
5HW proteins investigated show only 1Lb emission. But 5HW in a protein can also emit
from 1La and experimental data collected for W20LysM tandem protein show this for the
first time. For this protein dual emission was observed. Because the 1La dipole moment
is significantly larger than the 1Lb dipole moment, inhomogeneous broadening will induce
more spectral broadening at the 1La origin. A protein microenvironment increasing this
broadening may make 1La the lowest in energy [132], offering an explanation for the dual
emission of W20LysM tandem protein.
For the LysM proteins, the emission maxima for the Trp-containing proteins are 341 ±
1 nm [106], while for the four 5HW LysM proteins the emission maxima appear at 330 - 335
nm (data not shown). Likewise, the emission energies of many other single 5HW containing
proteins are blue-shifted compared to their wild type counterpart [133, 100, 134, 78]. Only
in a few cases a red-shift was reported [131, 79]. Hirst and coworkers calculated the
emission energy of six proteins containing either Trp or 5HW and found the 1La emission
energy of 5HW is typically ≈ 20 nm (0.2 eV) red-shifted compared to Trp[127]. For 5HW
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at a hydrophobic buried position, emission energies for the 1La state of Trp and 5HW were
calculated to be quite close to each other. Taken together, the available experimental data
of 5HW containing proteins indicates 1Lb is typically the emitting state, but the protein
matrix can promote 1La emission as presented here for the first time for W20LysM tandem
protein showing dual emission.
In conclusion, in this work we experimentally show emission of 5HI and free 5HW
occurs from the 1Lb state, a conclusion in line with previous spectroscopic observation
typical for 1Lb emission like a small dependence of λ
max on solvent polarity and a high
intrinsic anisotropy. Our conclusion is opposite to theoretical calculations predicting 1La
as the emitting state for these probes. The protein matrix can make 1La becoming the
emitting state, a result not believed to be possible for a long time but now supported
theoretically and experimentally. The ability of the protein matrix to tune the emitting
state can be exploited as a sensitive probe for monitoring protein conformational changes
and probing protein-ligand interactions. Available data however indicate that it might
be difficult to meet this condition as most reported 5HW containing proteins show only
characteristics corresponding with 1Lb emission.
Acknowledgments
We thank Dr. P.R. Callis for helpful discussions. This work was supported by the
nanotechnology network NanoNed.
60
Emitting state of 5-hydroxyindole, 5-hydroxytryptophan and 5-hydroxytryptophan
incorporated in proteins
4.6 Supplementary figures
Figure 4.5: Anisotropy excitation spectra of free 5HI in a glycerol glass at -50 ◦C.
Emission was recorded at 320 nm (square), 340 nm (circle) and 360 nm (triangle). B: Emission
wavelength dependence of the anisotropy of free 5HI in a glycerol glass at -50 ◦C.
Excitation wavelengths of 260 nm (square), 275 nm (circle), 290 nm (triangle), 305 nm (diamond)
were used.
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Figure 4.6: Fluorescence excitation spectra (square) of 5HW in a glycerol glass at
-50 ◦C and its resolved 1La (triangle) and 1Lb (circle) spectra for β = 67◦ (A) and β
= 90◦(B).
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Figure 4.7: Fluorescence excitation spectra (square) of 5HI in a glycerol glass at -50
◦C and its resolved 1La (triangle) and 1Lb (circle) spectra for β = 67◦ (A) and β =
90◦(B).
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Figure 4.8: Fluorescence decay kinetics of free 5HW at emission wavelengths 320 nm (a),
340 nm (b) and 360 nm (c). Fluorescence decay kinetics of 5HW containing W20LysM





In the last few decades, fluorescence spectroscopy has become a primary research tool
in the life sciences and other research fields like medicine and analytical chemistry. In
protein chemistry the aromatic amino acid tryptophan (Trp) plays an important role as
an intrinsic probe for investigations using this technique. Trp has attractive spectroscopic
properties, like a high sensitivity of the spectral energy and quantum yield for a change
in microenvironment which allows studying protein structure and dynamics. The high in-
trinsic anisotropy upon red-edge excitations makes it a valuable probe to investigate site
specifically the dynamics in a protein. In practice, these features can only be optimally
exploited if purified proteins are used containing only one or two Trp residues.
One approach to overcome this limitation is replacing the Trp of interest by a Trp
analogue, which can be biosynthetically incorporated and which shows a red shifted ab-
sorbance spectrum, compared to Trp. This allows selective excitation of the analogue in
the presence of other tryptophan-containing proteins. These Trp analogue-labelled pro-
teins are also known as spectrally enhanced alloproteins. One of the goals of this PhD
work was to explore the use of these proteins as molecular recognition element in a biosen-
sor. The ability to detect microbes this way has been investigated. Moreover, new routes
are presented for the production of alloproteins equipped with novel properties that can
be exploited in biosensor design and in other research fields.
A concise introduction about Trp fluorescence spectroscopy, incorporation of Trp ana-
logues into recombinant proteins, and LysM domains is given in chapter 1.
LysM domains are found in thousands of proteins of prokaryotic and eukaryotic origin.
Their affinity for peptidoglycan allows LysM-containing proteins to become non-covalently
attached to cell walls and other structures containing this material. A sensitive spectro-
scopic method allowing the direct monitoring of the binding event has not been reported.
In chapter 2 a fluorescence method is presented to directly measure the interaction of
a LysM domain with peptidoglycan. A Trp analogue fluorescence spectroscopy-based
method is presented requiring only a few µg of LysM. Four single Trp LysM proteins were
constructed and biosynthetically labelled with the Trp analogues 5-hydroxytryptophan
(5HW) and 7-azatryptophan. The red-shifted absorption spectra of these analogues allow
excitation at wavelengths where tryptophan does not absorb. Thus, samples containing
Trp can be analysed with this methodology. This method will help the LysM field in the
discovery of new ligands and addressing fundamental research questions like the kinetics
of the LysM-ligand interaction. Moreover, the presented single-Trp mutants may find
application in a biosensor for the detection of microbes.
To date, a limited number of Trp analogues have been biosynthetically incorporated
in proteins, including azaTrps, fluoroTrps, aminoTrps, and hydroxyTrp analogues. In al-
most all studies, an E. coli Trp auxotroph was employed as expression host. The high
substrate specificity of the enzyme tryptophan aminoacyl-tRNA synthetase (trpRS) in E.
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coli limits the incorporation of Trp analogues with bulkier substituents. In chapter 3 a
Lactococcus lactis Trp auxotroph expression system is presented able to biosynthetically
incorporate in proteins tryptophan analogues with bulky substituents (like chloro- and
bromotryptophan and also difluorotryptophan). Alloproteins containing these analogs
can now be easily produced in high yields. Coexpression of the trpRS of Lactococcus lac-
tis was essential to obtain these results. The developed system features the most relaxed
specificity for Trp analogue incorporation reported to date and gives a high alloprotein
yield.
Easy access to alloproteins containing chloro- or bromotryptophan offers new oppor-
tunities to study structure and dynamics of these proteins using Trp analogue phosphores-
cence spectroscopy. Chloro- or bromotryptophans are attractive intrinsic phosphorescence
probes because they are much less sensitive for quenchers in the medium, like oxygen. The
extremely high sensitivity of Trp phosphorescence for quenchers has limited widespread
use of this unique spectroscopic method.
A straightforward approach to investigate the involvement of a Trp residue in cation-pi
or pi-pi interactions is the characterization of a set of alloproteins, each containing a Trp
analogue with a different electron density distribution at the indole moiety. The presented
expression system is ideally suited to generate methyl and fluoro-substituted Trp analogue-
containing alloproteins for these investigations. To date, these alloproteins are produced
in extremely low amounts via an in vitro methodology using Xenopus laevis oocytes as
expression system. This limits analysis of these proteins to very sensitive methodologies
like patch-clamp. The availability of these proteins in mg quantities enables studies via
other methodologies including fluorescence spectroscopy, NMR, and calorimetry.
The method for the efficient incorporation of Trp analogues, described in chapter
3, enabled studying the emitting state of 5HW in proteins and this work is presented
in chapter 4. A controversy exists in the current literature about the emitting state of
5HW and 5-hydroxyindole (5HI). For a long time it was assumed that these probes were
emitting only from the 1Lb state, although conclusive experimental data, like excitation
anisotropy spectra, have not been reported. Recently, two computational studies were
published claiming that 1La is the emitting state of 5HI and 5HW when present in polar
solvents, including water, and that it is also typically the emitting state of 5HW incor-
porated in proteins. In chapter 4 convincing experimental data is presented about the
emitting state of 5HI, 5HW, and of 5HW incorporated in 4 proteins. 1Lb is the emitting
state in all these samples except in one protein, which shows dual emission from both the
1La and
1Lb states.
Given the large differences in the properties of the 1La and
1Lb states, fluorescent
data can only be properly interpreted if the emitting state is known. The data presented
in chapter 4 undermines the long standing consensus view that 1Lb is the only emitting
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state of this popular Trp analogue, as well as the conclusion of the recent papers claiming
that 1La is typically the emitting state. The work presented in chapter 4 settles this
issue and a straightforward procedure is presented to estimate the emitting state of these
probes. We foresee that this work will become a reference study for future work employing





In de laatste decennia is fluorescentiespectroscopie een belangrijke onderzoeksmeth-
ode geworden in de levenswetenschappen en onderzoeksgebieden zoals geneeskunde en
analytische chemie. Fluorescentiespectroscopie wordt ook veelvuldig toegepast in ei-
witchemisch onderzoek, waarbij het aromatische aminozuur tryptofaan (Trp) vaak wordt
gebruikt als fluorescentieprobe. Trp heeft interessante eigenschappen, zoals een hoge
gevoeligheid van de emissie-energie en de lichtopbrengst voor een verandering in de micro-
omgeving van Trp. Dit maakt Trp erg geschikt voor het bestuderen van eiwitstructuren en
eiwitdynamica. Ook de hoge intrinsieke anisotropie van Trp bij excitatie met golflengtes
boven 295 nm biedt goede mogelijkheden om eiwitten te bestuderen, met name met be-
trekking tot de lokale dynamica van een eiwit. Deze eigenschappen kunnen in de praktijk
echter alleen optimaal benut worden, als gezuiverd eiwit met slechts 1 of 2 Trp-residuen
gebruikt wordt.
Ee´n mogelijkheid om een mengsel van eiwitten m.b.v. fluorescentie te bestuderen is
het vervangen van een specifieke Trp in e´e´n van de eiwitten door een Trp-analogon dat
absorbeert bij hogere golflengtes dan Trp zelf. Dit maakt het selectief exciteren van het
Trp-analogon mogelijk in aanwezigheid van andere Trp-bevattende eiwitten. Vanwege de
aanwezigheid van een onnatuurlijk aminozuur worden deze eiwitten ook wel alloprote¨ınes
genoemd. Ee´n van de doelen van het promotie project was te onderzoeken of Trp anal-
ogon bevattende eiwitten gebruikt kunnen worden als moleculair herkenningselement in
een biosensor. Het onderzoek heeft zich voornamelijk toegespitst op de detectie van cel-
wandmateriaal afkomstig van bacterie¨n. Daarnaast zijn een aantal nieuwe procedures
ontwikkeld voor de productie van alloprote¨ınes met eigenschappen die van belang kunnen
zijn voor toepassing in biosensoren en in fundamenteel eiwitchemisch onderzoek.
In hoofdstuk 1 wordt algemene informatie gegeven over Trp fluorescentiespectro-
scopie, het inbouwen van Trp-analoga in recombinante eiwitten, en over LysM domeinen.
LysM domeinen zijn te vinden in duizenden verschillende eiwitten van prokaryotische en
eukaryotische oorsprong. Door hun affiniteit voor peptidoglycan kunnen eiwitten die een
LysM domein bevatten binden aan celwanden en aan andere peptidoglycan bevattende
stoffen. Tot nu toe was er geen gevoelige spectroscopische methode voorhanden om de
interactie tussen LysM domeinen en de celwand direct te kunnen volgen. In hoofd-
stuk 2 wordt een fluorescentiemethode gepresenteerd waarmee deze interactie gevolgd
kan worden. Voor deze op een Trp-analogon gebaseerde methode is slechts een paar µg
LysM nodig per meting. In dit hoofdstuk wordt de productie beschreven van vier ver-
schillende LysM-eiwitten die slechts e´e´n Trp bevatten, elk biosynthetisch gelabeld met
de Trp-analoga 5-hydroxytryptofaan (5HW) en 7-azatryptofaan. De absorptiespectra van
deze analoga vertonen een verschuiving naar hogere golflengte, vergeleken met het ab-
sorptiespectrum van Trp. Dit zorgt ervoor dat monsters die ook gewone Trp bevatten
via deze methodologie goed geanalyseerd kunnen worden, aangezien gee¨xciteerd wordt bij
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golflengtes van 310-320 nm. De beschreven methode kan het LysM vakgebied helpen bij
het ontdekken van nieuwe liganden en het bestuderen van de kinetiek van de LysM-ligand
interacties. Daarnaast kunnen de beschreven LysM alloprote¨ınes een toepassing vinden
in biosensoren voor het detecteren van bacterie¨n.
Tot op heden is er slechts een beperkt aantal Trp-analoga biosynthetisch ingebouwd
in eiwitten, zoals bijvoorbeeld aza-, fluoro-, amino- en hydroxytryptofanen. In bijna alle
studies werd een Trp auxotrofe E. coli stam gebruikt als expressiesysteem. De hoge sub-
straatspecificiteit van het enzym tryptofaan aminoacyl-tRNA synthetase (trpRS) in E. coli
beperkt het inbouwen van Trp-analoga met grotere substituenten. In hoofdstuk 3 wordt
een Lactococcus lactis Trp auxotroof expressie systeem beschreven die de biosynthetische
inbouw van Trp analoga met grotere substituenten (zoals chloro- en bromotryptofaan,
alsmede difluorotryptofaan) mogelijk maakt. Alloprote¨ınes die deze analoga bevatten
kunnen nu gemakkelijk in hoge opbrengst worden geproduceerd. Co-expressie van trpRS
van Lactococcus lactis was essentieel om dit mogelijk te maken.
Het op een eenvoudige manier produceren van chloro- of bromotryptofaan bevat-
tende alloprote¨ınes opent ook nieuwe mogelijkheden om de structuur en dynamica van
deze eiwitten te bestuderen met behulp van fosforescentie spectroscopie. Chloro- of bro-
motryptofanen zijn aantrekkelijke intrinsieke fosforescentie-probes, omdat zij veel minder
gevoelig zijn voor quenchers zoals zuurstof. De extreem hoge quencher-gevoeligheid van
Trp-fosforescentie heeft toepassing van deze spectroscopische methode in eiwitonderzoek
aanzienlijk belemmerd.
Een goede manier om de rol van een Trp-residue in kation-pi of pi-pi interacties te
onderzoeken, is het bestuderen van deze interactie in een reeks alloprote¨ınes die elk
een Trp-analogon bevatten met een verschillende electronenverdeling in de indool groep.
Het hierboven genoemden expressiesysteem is uitermate geschikt om methyl- en fluor-
gesubstitueerde Trp bevattende alloprote¨ınes te produceren. Tot nu toe werden deze
alloprote¨ınes enkel geproduceerd met een zeer lage opbrengst via een in vitro methode die
gebruik maakt van Xenopus laevis oocyten als expressiesysteem. Dit beperkt de analyse
van deze eiwitten tot zeer gevoelige methodes zoals patch-clamp. De nieuwe mogelijkheid
om deze eiwitten op mg-schaal te produceren opent de weg voor experimenteel werk via
andere analyse methoden zoals fluorescentie, NMR en calorimetrie.
De methode voor de efficie¨nte inbouw van Trp-analoga, zoals beschreven in hoofd-
stuk 3, maakte het mogelijk om de emissietoestand van 5HW in eiwitten te bestuderen
en dit werk is beschreven in hoofdstuk 4. De literatuur is niet eenduidig over de emissi-
etoestand van 5HW en 5-hydroxyindool (5HI). Lange tijd werd aangenomen dat deze flu-
oroforen alleen emissie vertonen vanaf de 1Lb toestand, maar overtuigend experimenteel
bewijs, uit bijvoorbeeld excitatie anisotropie spectra, was niet voorhanden. In twee re-
cente theoretische studies werd geconcludeerd dat 1La de emissietoestand is van 5HI en
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5HW in polaire oplosmiddelen, waaronder water, en dat dit ook geldt voor 5HW wanneer
deze verbinding is ingebouwd in een eiwit. In hoofdstuk 4 worden experimentele data
gepresenteerd over de emissietoestand van vrij 5HI en 5HW, en van 5HW ingebouwd in
een eiwit. Hieruit blijkt dat in de meeste gevallen 1Lb de emissietoestand is. Echter, e´e´n
eiwit vertoont zowel 1La en
1Lb emissie.
5HW fluorescentie data kunnen alleen correct worden ge¨ınterpreteerd als de emissi-
etoestand bekend is. De data in hoofdstuk 4 ontkrachten de sinds lang geaccepteerde
consensus dat 1Lb de enige emissietoestand is van dit populaire Trp-analogon, en ook de
conclusies uit recentere studies die beschrijven dat emissie veelal via 1La plaats vindt.
Het onderzoek beschreven in hoofdstuk 4 lost deze controverse op en draagt een een-
voudige procedure aan om de emissietoestand van deze fluoroforen te bepalen. Dit on-
derzoek kan een referentiestudie worden voor toekomstige studies die gebruik maken van
5-hydroxyindool, 5-hydroxytryptofaan en de neurotransmitter serotonine als fluorescentie-
probes.
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